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ABSTRACT 
MICHELLE S. ITANO: Composition, Structure, Dynamics and 
Function of C-Type Lectin Receptor Domains 
 (Under the direction of Ken Jacobson) 
 
DC-SIGN, a Ca2+-dependent C-type transmembrane lectin, is found assembled in 
microdomains on the plasma membranes of dendritic cells. These microdomains bind a 
large variety of pathogens and facilitate their uptake for subsequent antigen presentation. 
In these studies, DC-SIGN dynamics and distribution in microdomains have been 
explored with several fluorescence microscopy methods and compared with those for 
influenza hemagglutinin (HA), which is also found in plasma membrane microdomains. 
Fluorescence recovery after photobleaching (FRAP), line-scan fluorescence correlation 
spectroscopy and defined valency quantum dot single particle tracking measurements 
showed that full-length and cytoplasmically truncated DC-SIGN is essentially 
immobilized in microdomains, whereas HA is laterally mobile within and outside 
microdomains and exchanges between these two regions. By contrast, FRAP 
measurements indicated that inner leaflet lipids are able to move through DC-SIGN 
microdomains. Wide-field fluorescence imaging indicated that DC-SIGN microdomains 
may contain other C-type lectins and that the DC-SIGN cytoplasmic region is not 
required for microdomain formation. A super-resolution imaging technique, Blink 
Microscopy (Blink), was applied to further investigate the lateral distribution of DC-
SIGN.  Blink indicates that DC-SIGN, another C-type lectin (CD206), and HA are all 
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localized in small (~80 nm in diameter) nanodomains. DC-SIGN and CD206 
nanodomains are randomly distributed on the plasma membrane, whereas HA 
nanodomains cluster on length scales up to several microns. We estimate, as a lower 
limit, that DC-SIGN and HA nanodomains contain on average two tetramers or two 
trimers, respectively, while CD206 is often non-oligomerized. Two-color Blink 
determined that different C-type lectins rarely occupy the same nanodomain although 
they appear co-localized using widefield microscopy. Thus, a novel domain structure 
emerges in which elemental nanodomains, potentially capable of binding viruses, are 
organized in a random fashion; evidently, these nanodomains can be clustered into larger 
microdomains that act as receptor platforms for larger pathogens like yeasts. These 
results contribute significantly to a young field directed at elucidation of the complex 
intradomain structural features underlying function. 
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CHAPTER 1 
Introduction 
 
 This chapter contains an overview of the doctoral work described in the six 
chapters of this dissertation. The research presented in this dissertation will relate to 
proteins expressed on dendritic cells, the main antigen presenting cells in the immune 
system.  Dendritic cells express receptors, including the C-type lectins, that recognize 
pathogen-associated molecular patterns across their cell surface. In particular, two 
members of the C-type lectin family of proteins, DC-SIGN and CD206, are expressed in 
microdomains on the plasma membrane and are important receptors for many pathogens 
including HIV and Candida albicans. The work described in the subsequent chapters uses 
cutting-edge fluorescence microscopy techniques to characterize the composition, 
structure, dynamics, and function of single C-type lectin molecules in these domains on 
the plasma membrane. 
 
 The biological relevance of protein and lipid domains in the plasma 
membrane is discussed in Chapter 2. The work in Chapter 2 is reproduced/adapted with 
permission from a published article that was a part of the F1000 series of Biology Reports 
(Neumann AK, Itano MS, Jacobson K, 2010. Understanding lipid rafts and other 
related membrane domains, F1000 Biology Reports, 2:31. doi: 10.3410/B2-31).  
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 In Chapter 3, the background and methodology specific for the super-
resolution method called Blink Microscopy is provided. Chapter 3, a collaboration with 
investigators at the Technical University of Braunschweig who developed the Blink 
Microscopy method, will be published as an invited chapter by Methods in Molecular 
Biology (reproduced/adapted with permission from: Steinhauer C, Itano MS, Tinnefeld P.  
Super-resolution fluorescence imaging with blink microscopy, new volume entitled 
"Nanoimaging: Methods and Protocols."  Methods in Molecular Biology. USA: Humana 
Press; 2012, accepted book chapter). Blink Microscopy, which utilizes the successive 
localization of single molecules, is the predominant method used for the work presented 
in Chapter 5. 
 
 The work presented in Chapter 4 characterizes the composition of C-type lectin 
microdomains and contrasts the immobility of DC-SIGN and its mutants with a laterally 
mobile viral envelope protein from influenza. This chapter, conducted in collaboration 
with Nancy L. Thompson (Dept. of Chemistry, University of North Carolina), presents 
the results of three complementary modern measurements of the dynamics of proteins on 
the level of single, living cells and single molecules. To implement two of these methods, 
work was performed with input from Enrico Gratton (Director of the Laboratory for 
Fluorescence Dynamics at the University of California-Irvine) on aspects of fluorescence 
correlation microscopy, and with the Wolfgang Parak laboratory (Marburg University in 
Marburg, Germany) to generate quantum dots of defined valency. A discussion on how 
the particular dynamic and composition characteristics of DC-SIGN domains may 
contribute to the immunological function of these protein domains is also presented.  The 
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work in this chapter is reproduced/adapted with permission from a paper published in the 
Biophysical Journal (Itano MS, Neumann AK, Liu P, Zhang F, Gratton E, Parak WJ, 
Thompson NL, Jacobson K, 2011.  Dynamics of DC-SIGN and influenza 
hemagglutinin in microdomains on plasma membranes, Biophysical Journal, 
100(11):2662-70. doi: 10.1016/j.bbr.2011.03.031). 
  
 The composition, structure, and distribution of CD206 and DC-SIGN C-type 
lectin domains are investigated using the super-resolution technique Blink Microscopy in 
Chapter 5.  This work was conducted in collaboration with Nancy L. Thompson and 
investigators in Philip Tinnefeld’s lab.  The data was collected in Germany, primarily 
during three separate visits to Munich and Braunschweig for two to three weeks each. 
Two-color Blink Microscopy was performed to investigate whether two proteins, which 
appear to be co-localized by using widefield microscopy (with a resolution of ~300 nm), 
are actually co-localized when viewed at a higher spatial resolution (~30 nm).  The work 
presented in Chapter 5 was reproduced/adapted with permission from a paper published 
in the Biophysical Journal (Itano MS, Steinhauer C, Schmied J, Forthmann C, Liu P, 
Neumann AK, Thompson NL, Tinnefeld P, Jacobson K, 2012. Super-resolution imaging 
of C-type lectin and influenza hemagglutinin nanodomains on plasma membranes 
using Blink Microscopy, Biophysical Journal, 102(7):1534-42. doi: 
1.1016/j.bpj.2012.02.022). 
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 In Chapter 6, the conclusions generated from the work presented in this 
dissertation are discussed. An outlook on how these conclusions affect the current 
understanding how proteins are organized on the plasma membrane is also provided.   
 
CHAPTER 2 
Understanding Lipid Rafts and Other Related Membrane Domains1 
 
2.1 SUMMARY 
 
Evidence in support of the classical lipid raft hypothesis has remained elusive. 
Data suggests that transmembrane proteins and the actin-containing cortical cytoskeleton 
can organize lipids into short-lived nanoscale assemblies that can be assembled into 
larger domains under certain conditions. This supports an evolving view in which 
interactions between lipids, cholesterol, and proteins create and maintain lateral 
heterogeneity in the cell membrane. 
 
 
                                                 
1 Reproduced/apdapted with permission from: 
Neumann AK, Itano MS, Jacobson K, 2010. Understanding lipid rafts and other 
related membrane domains, F1000 Biology Reports, 2:31. doi: 10.3410/B2-31 
 
Michelle S. Itano primarily contributed to writing the “Major recent advances” portion of 
this manuscript and also contributed to the overall organization, writing, and editing of 
this manuscript, including figure preparation. 
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2.2 INTRODUCTION AND CONTEXT 
 
Differential lipid composition between the apical and basolateral membrane 
domains of epithelial cell plasma membranes [1, 2] made it clear that membrane lipids 
are not laterally distributed in a homogeneous fashion. The lipid raft hypothesis was 
developed to explain lateral separation of bilayer lipids, and this idea quickly found 
applications in viral budding, endocytosis and signal transduction (reviewed in [3]). In 
model membranes, lipids can separate into microscopically resolvable raft-like domains 
[4]. Plasma membrane surrogates formed by chemical membrane blebbing or cell 
swelling procedures also show phase behavior [5-8]. Similar domains are not evident 
upon direct observation of unperturbed plasma membranes in living cells, but the non-
equilibrium nature of cell membranes, including endocytosis, exocytosis, and other 
motile processes, may prevent overt phase separation. Likewise, quantitative analysis of 
lipid-anchored protein and lipid diffusion in cell membranes by fluorescence recovery 
after photobleaching (FRAP), Förster resonance energy transfer (FRET), and 
fluorescence correlation spectroscopy (FCS) [9-11] indicated that rafts in the plasma 
membrane of resting cells must be very small or ephemeral (or both), forcing an 
evolution of the lipid raft hypothesis. These tiny clusters do not represent lipid phase 
separations but are probably short-range ordering imposed upon lipids by transmembrane 
proteins and cortical actin structures. Thus, the current challenge for the field is to 
understand the interplay between protein and lipid that converts the exceedingly small, 
unstable clusters of components into larger, more stable membrane microdomains 
required for function [3, 12]. 
 
 
7 
2.3 MAJOR RECENT ADVANCES 
 
The recent development of sensitive quantitative microscopy methods has 
advanced our knowledge of lipid dynamics in resting cells. The diffusion of raft lipids 
(e.g., sphingomyelin) and non-raft lipids (e.g., phosphatidylethanolamine) was measured 
by an elegant FCS technique within regions as small as 30 nm in diameter using 
stimulation emission depletion fluorescence microscopy. The results indicate that raft 
lipids, but not non-raft lipids, are indeed preferentially trapped, albeit for short distances 
(<20 nm) and for short periods (10-20 ms) [13]. HomoFRET measurements, combining 
FRAP, emission anisotropy, and theoretical model fitting to test models of lateral 
organization in the membrane, were used to determine the degree of clustering of 
glycosylphosphatidylinositol (GPI)-anchored proteins in the plasma membrane [14, 15]. 
The formation of GPI-anchored protein nanoclusters (of ~4 molecules or even less) [14] 
is an active process involving both actin and myosin, and these nanoclusters are non-
randomly distributed into larger domains of <450 nm [15]. Additionally, high-speed 
single-particle tracking (50 kHz) revealed that GPI-anchored proteins, along with other 
membrane proteins, undergo rapid hop diffusion between 40 nm actin-regulated 
compartments, with a compartment dwell time of 1-3 ms on average [16]. However, 
when GPI-anchored proteins were deliberately cross-linked by gold or quantum dot 
particles, they underwent transient confinement or ‘STALL’ (stimulation-induced 
temporary arrest of lateral diffusion) from a cholesterol-dependent nanodomain in a Src 
family kinase mediated manner [17-19]. A recent study identified a transmembrane 
protein (carboxyl-terminal Src kinase [Csk]-binding protein) involved in the linkage 
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between the particle-cross-linked GPI-anchored protein, Thy1, and the cytoskeleton 
(Figure 2.1) [20].   
 
Larger microdomains involve raft lipids and specific membrane proteins. The 
lipid envelopes of influenza and HIV virions, but not those of the vesicular stomatitis 
virus (VSV) or Semliki Forest virus (SFV), are enriched in raft-like lipids, leading to the 
notion that these viruses bud from lipid microdomains in the plasma membrane [21-25]. 
By contrast, the lipidomes of VSV and SFV are very similar to each other and to that of 
the plasma membrane suggesting that these viruses do not select or generate lipid raft 
domains for budding [25].   
 
The protein and lipid environment of the budding domains of hemagglutinin (HA) 
and HIV has been the source of several recent papers examining the process of viral 
budding using quantitative live-cell imaging techniques. Influenza buds from HA clusters 
(ranging up to micrometers in diameter) [26] regulated by the HA transmembrane region 
length and palmitoylation [27]. Recent fluorescence lifetime imaging microscopy 
(FLIM)-FRET experiments in living cells indicate that HA co-localizes with lipid 
microdomain markers, further supporting the role of lipid-protein interactions in 
influenza virus budding [28, 29]. Proton magic angle spinning nuclear magnetic 
resonance was used to detect a minor fraction (~10-15 %) of liquid-ordered membrane 
phospholipids in HA virions and virion lipid extracts at 37°C. While lipid ordering 
increased at lower temperatures it was not required for virion fusion with target 
membranes [30]. 
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Progressive recruitment of cytoplasmic HIV-1 Gag to the membrane, via 
posttranslational acyl lipid modification and PIP2/basic residue interactions, forms 
membrane domains that culminate in virion budding [31-33]. While the HIV-1 lipid 
envelope composition indicates enrichment in lipids and proteins associated with ‘rafts’ 
[21], paradoxically, one group failed to observe an enrichment of enhanced green 
fluorescent protein (EGFP)-GPI at Gag domains in living cells [32], suggesting that the 
local lipid microenvironment may not exactly parallel the classic raft lipid composition. 
Recent work has implicated the tetraspanin family of proteins in Gag domain formation 
and function. Tetraspanins, a widely expressed and highly conserved class of 
transmembrane proteins (reviewed in [34]), form tetraspanin-enriched microdomains 
(TEMs) through lateral tetraspanin-tetraspanin interactions and binding to non-
tetraspanin membrane proteins. HIV-1 Gag is targeted to TEMs and virus buds from 
these domains [35, 36]. Tetraspanins can be palmitoylated [37] and the lipid environment 
within TEMs contains cholesterol, but GPI-anchored proteins and caveolin are not 
enriched in TEMs (reviewed in [38]). Recently, cholesterol and tetraspanin 
palmitoylation were implicated in the confined diffusion and co-diffusion (of two 
tetraspanin molecules) of the tetraspanin CD9 [39]. Tetraspanins appear to induce order 
in the plasma membrane by virtue of protein clustering, but they likely also stabilize lipid 
microenvironments in the plasma membrane allowing for lateral organization of HIV-1 
Gag and virion budding.   
 
Some lectin-based membrane domains form in the absence of posttranslational 
lipid modifications or known lipid binding activity. Dendritic cell-specific intracellular 
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adhesion molecule-3-grabbing non-integrin (DC-SIGN), a tetrameric C-type lectin with 
affinity for high-mannose glycans, forms microdomains on the plasma membrane [40-42] 
that serve as high-avidity binding sites for numerous pathogens. A previous report 
suggested that DC-SIGN interacts with lipid rafts [40], but this was based on detergent 
insolubility and cholera toxin co-localization assays, which generally do not faithfully 
report on intrinsic membrane lateral heterogeneity. Also, DC-SIGN domains do not 
depend on cholesterol (unpublished data). Surprisingly, DC-SIGN domains do not 
recover following photobleaching [42]. This result implies that DC-SIGN within domains 
does not exchange with the surrounding membrane.  The source of this stability remains a 
mystery, and its cause may not reside in the membrane-apposed cytoskeleton but in 
extracellular cross-linking factors such as galectins (reviewed in [43]).  DC-SIGN 
membrane domains that are multiplexed with another C-type lectin, CD206 (unpublished 
data), appear to mediate the formation of fungipods, novel cellular protrusive structures 
involved in fungal recognition by dendritic cells (Figure 2.2) [44]. Thus, the lateral 
heterogeneity in membranes provided by rafts and other microdomains continues to 
provide surprising functional consequences. 
 
2.4 FUTURE DIRECTIONS 
 
A variety of membrane domain forming systems have a wide gamut of lipid and 
protein constituents and possess a correspondingly broad range of functions. Recent 
advances have shown that preferential lipid trapping or confinement in the resting plasma 
membrane occurs only on very small spatiotemporal scales. Critical attention must be 
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paid when determining if and when such confinement becomes biologically meaningful 
for processes such as endocytosis and signal transduction. While lipid ordering can be 
stabilized by oligomerization of membrane-associated proteins (i.e., GM1 crosslinking, 
influenza HA clustering), the lipids in these domains may still exchange between domain 
and surrounding membranes, making even these stabilized raft-like domains dynamic 
environments. At what point does a membrane domain become stable enough to be 
biologically relevant? What is the range of protein and lipid turnover rates seen in 
membrane domains and are there different turnover rates for each constituent? It is likely 
that a spectrum of membrane microdomains exists with different compositions and 
physical characteristics suited to their diverse purposes. The lipid species and their 
ordering within raft-like complexes appear to be key factors in determining intradomain 
cohesiveness and resultant domain size and lifetime. 
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2.6 FIGURE LEGENDS 
 
Figure 2.1. EBP50-ERM assembly is the common adaptor complex for linking 
cholesterol-dependent Thy-1 clusters to the membrane apposed cytoskeleton.  The 
GPI-anchored protein Thy-1 engages membrane lipids and proteins for transmembrane 
signaling. Thy-1 crosslinking by streptavidin-coated quantum dots aggregates GPI lipid 
tails in the outer leaflet of the plasma membrane in a cholesterol-dependent manner. 
Carboxyl-terminal Src kinase (Csk)-binding protein (CBP), a transmembrane protein, is 
recruited to or captured by Thy-1 clusters along with Src-family kinase substrates (KS). 
CBP or KS (or both) are phosphorylated by Src-family kinases (SFK), enabling CBP to 
bind to actin filaments via an EBP50-ERM (Ezrin-binding phosphoprotein 50-
ezrin/radixin/moesin) adaptor linkage resulting in a transient anchorage. When either 
CBP or the adaptors are dephosphorylated by an unspecified protein tyrosine phosphatase 
(PTP), the anchorage is terminated. Image was reproduced/adapted with permission from 
[20]; Chen et al., J Cell Sci 2009,  doi: 10.1242/jcs.049346. 
 
Figure 2.2. C-type lectin domains and fungipod formation.  C-type lectins (CLRs) 
form a type of plasma membrane domain that is not dependent on cholesterol. (A) Plasma 
membrane domains containing mixtures (yellow) of dendritic cell-specific intracellular 
adhesion molecule-3-grabbing non-integrin (DC-SIGN) (green) and CD206 (red) are 
observed on a monocyte-derived dendritic cell (DC) by immunofluorescence. DC-SIGN 
domains are known sites of binding and entry for a range of pathogens including HIV-1. 
(B) Yeast cell wall material is sensed by these CLR membrane domains, triggering a 
unique protrusive response, the fungipod. The image shows an example of a DC fungipod 
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formed via CD206 ligation by a fixed Saccharomyces cerevisiae particle (zymosan), 
visualized by scanning electron microscopy (9500×). Figure 2.2b was 
reproduced/adapted with permission from [44], Neumann & Jacobson, PLoS Pathog 
2010, doi:10.1371/journal.ppat.1000760. 
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FIGURE 2.1 
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FIGURE 2.2 
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CHAPTER 3 
Super-Resolution Fluorescence Imaging with Blink Microscopy1 
 
3.1 SUMMARY 
 
 Recently, a new approach for super-resolution microscopy has emerged which is 
based on the successive localization of single molecules. The majority of molecules are 
prepared to reside in a non-fluorescent dark state, leaving only a few single molecules 
fluorescing. The single molecules can subsequently be localized on the camera image. 
Successive localization of all molecules allows reconstruction of a super-resolved image 
of the labeled structure. A variety of ways for limiting the number of locatable molecules 
have been developed recently which expand this current field of imaging. Here we 
describe a super-resolution microscopy method that employs the use of reversible, 
generic dark states, for example radical ion states. This method requires only a single 
laser source and can be carried out with many fluorescent dyes, and in some cases even in 
living cells. We provide a step-by-step procedure for this method, which we have called 
Blink Microscopy. 
                                                 
1 Reproduced/adapted with permission from: 
Steinhauer C, Itano MS, Tinnefeld P.  Super-resolution fluorescence imaging with blink 
microscopy, new volume entitled "Nanoimaging: Methods and Protocols."  Methods in 
Molecular Biology. USA: Humana Press; 2012, accepted book chapter. 
 
Michelle S. Itano primarily contributed to writing the “Sample Preparation” and “Post-
Processing” sections, providing the data for Figure 3.3, and also contributed to the overall 
organization, writing and editing of this manuscript. 
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3.2 INTRODUCTION 
 
Since the publication of STORM and (F)PALM in 2006 [1-3] several similar 
approaches have been developed based on the wide-field detection and localization of 
single molecules [4-14]. These approaches mainly differ from each other in the way that 
single molecule fluorescence events are generated. Generally, this is achieved by 
affecting how the majority of fluorophores are prepared to reside in a non-fluorescent 
state while a small subset emits, resulting in point-spread functions originating from 
single molecules. An overview of different methods can be found in review articles in 
various journals [15-20].  
 
This chapter focuses on, and describes in detail, the unique features of Blink 
Microscopy. Blink Microscopy employs single-molecule blinking, a well-known feature 
of organic fluorophores, to cycle dyes between a fluorescent ON-state and a non-
fluorescent OFF-state. 
 
With the exception of stimulated emission depletion microscopy (STED) and 
other realizations of the RESOLFT (REversible Saturatable OpticaL Fluorescence 
Transitions) concept [17], many emerging super-resolution (SR) imaging methods are 
based on the successive localization of single molecules [1, 2]. In these methods, the 
majority of molecules are prepared to reside in a non-fluorescent dark state, leaving only 
a few single molecules fluorescing. These single molecules are subsequently localized by 
fitting a two-dimensional Gaussian function to the point spread functions (PSFs) of their 
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fluorescence intensities. This temporal separation of fluorescence is the most crucial step 
in localization-based microscopy; how to achieve this separation using organic 
fluorophores is a major focus of the following sections. The super-resolved image is then 
reconstructed from all single-molecule localizations. An example of Blink Microscopy 
data is shown in Figure 3.1. 
 
Interestingly, both STED/RESOLFT and localization-based approaches can use 
the same types of organic fluorophores, although the photophysical requirements for the 
fluorophores are considerably different. Both approaches require very photostable 
fluorophores that can be switched between an ON- and an OFF-state [16, 17]. One 
exemplary method exploits generic dark states (e.g. radical anion states) of the 
fluorophores in order to switch the major fraction of molecules OFF, so that the 
remaining subpopulation of molecules can be precisely localized. In this method, 
fluorescent dyes are switched OFF by transiently accepting an electron from a reductant 
molecule, which then yields dark states of up to several hundred seconds (Figure 3.2 A) 
[6, 21, 22]. Such dark states appear as blinking in single-molecule intensity transients 
(see Figure 3.2 B). Therefore, this technique has been termed “Blink Microscopy”.  
 
To rationalize the blinking, we take a brief look at the thermodynamics of 
photoinduced electron transfer reactions. Following excitation, the fluorescent dye is 
shelved from the ground state, S0, to the first excited single state, S1. In other words, the 
dye has entered a state of higher energy. In this state, the dye is a better electron acceptor 
than it was when it was in the ground state because the highest occupied molecular 
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orbital of the molecule is only singly occupied, and can therefore accept an electron quite 
easily. When a putative electron donor such as ascorbic acid or a thiolate ion collides 
with a dye in the excited singlet or triplet state, electron transfer to the dye can occur. The 
lifetime of the radical anion (for a dye molecule with an assumed neutral ground state) 
depends on the stability of the radical anion and the concentration of potential electron 
acceptors, such as oxygen. Thus, the lifetime can be controlled in vitro by adapting the 
oxidant (e.g. the oxygen) concentration. For in vivo measurements, certain dyes that 
show sufficiently long OFF-state lifetimes in physiological oxygen concentrations have 
to be used. Due to their high reduction potentials, examples of suitable dyes include the 
oxazines ATTO655, ATTO680, and ATTO700 [16, 22].  
 
Long OFF-states are of profound importance for super-resolution microscopy 
methods that utilize successive single-molecule localizations. The OFF-state lifetime and 
the time it takes to read out the photons emitted during one ON-state are crucial 
parameters affecting the obtainable resolution. More molecules can be registered for an 
area of the size of the point-spread function when the ratio of OFF- to ON- times is large. 
This requires the use of dyes with long OFF-states, comparably strong lasers, and fast 
cameras to enable fast readouts [16].  
 
Belonging to the class of techniques that employ successive single-molecule 
localizations, Blink Microscopy distinguishes itself by working with common organic 
dyes and requiring only one laser (for each color, in multi-color applications). In addition, 
Blink Microscopy can work in the presence of oxygen, and offers a rather broad range of 
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possible buffer conditions that are close to physiological. Blink Microscopy has been 
used to study cytoskeletal structures, such as actin filaments in fixed cells, amyloid 
aggregates, DNA nanostructures, and single-molecule assembled structures [6, 22-25]. In 
parallel, very similar techniques have been developed by the Sauer and the Hell 
laboratories, which have been termed dSTORM and GSDIM [5, 7, 26], respectively, 
showing that single-molecule blinking can even be applied in living cells [27, 28]. 
 
In this article, we provide a detailed protocol for Blink Microscopy, including the 
microscope setup, chemical and sample preparation, measurement procedures, and issues 
to consider for data analysis and trouble-shooting. The method is exemplarily 
demonstrated by imaging DC-SIGN, a transmembrane lectin that forms domains on the 
membrane of dendritic cells. These domains are commonly too small to be resolved by 
conventional fluorescence microscopy [29]. 
 
3.3 MATERIALS 
 
3.3.1 Chemicals and Consumables 
1. MilliQ water 
2. PBS, pH 7.4, preferentially as tablets to dissolve in water 
3. Ascorbic acid (AA) 
4. Methyl viologen (MV) 
5. Mercaptoethylamine (MEA) 
6. Beta-mercaptoethanol (ME) 
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7. TCEP (Sigma 646547) 
8. Tris 
9. Catalase (Sigma C 100-50 mg) 
10. Glucose oxidase (Sigma G2133-50KU) 
11. Glucose 
12. Glycerol 86 % 
13. LabTek chambered coverglasses (Nunc 155411) 
14. 96-well Plate sealing sheets 
15. 16 % Para-formaldehyde (PFA) stock solution 
16. Primary antibody corresponding to a protein of interest 
17. Secondary antibody, preferably unlabeled Fab2 fragments 
18. Amine reactive dye, e.g. ATTO655 NHS-ester. Dissolve in DMF, make 0.1 
mg aliquots and dry in a speed-vac. Store at -20 °C. 
19. Oxygen scavenging stock solution (20×): 5 mL 100 mM Tris-HCl, 25 mM 
KCl, pH 7.5; 5 mL Glycerol (86 %); 40 µl TCEP (0.5 M); 40 µl Catalase (20 
mg/mL as supplied); 10 mg Glucose oxidase.  Store in working aliquots at -20 
°C.  Due to its negligible influence on dye photophysics, TCEP is used instead 
of DTT.  
20. NAP-5 Columns (GE Healthcare) 
21. NanoRuler calibration standards to test sub-diffraction resolution (www.sts-
nano.com) 
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3.3.2 Microscope 
1. Leica SR-GSD, Zeiss Elyra PAL-M or Nikon nSTORM commercial 
microscope system 
2. Appropriate excitation laser with at least 100 mW output power 
3. High-quality emission and excitation filters 
4. High numerical aperture (≥1.4) oil-immersion objective with 60× or 100× 
magnification 
5. Back-illuminated EMCCD-camera 
6. Stage micrometer for pixel size calibration 
 
3.4 METHODS 
 
3.4.1 Sample Preparation 
Cells 
  Cells are grown in standard media and at recommended conditions. 
Growing the cells on LabTek chambered coverglass slides offers the advantages 
that they can easily be transferred to the microscope, buffers can be changed 
easily, and chambers can be sealed for oxygen removal. When using other non-
glass cell culture slides, the oxygen permeability of some plastics should be 
considered. 
  
 Detailed conditions for the proper growth and fixation of cells depend 
strongly on the type of cells used and the molecule being imaged, and are not 
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described here. However, it is important to note that fixation chemicals may have 
an influence on dye photophysics. In addition, fixation methods, especially those 
which use hardening media, might alter the shape of the structures of interest. 
Dehydrating formulas, for example, tend to flatten cells and change the 
appearance of the nucleus [30]. Therefore, if Blink Microscopy is unsuccessful or 
yields unexpected results, you may want to consider using alternate methods for 
fixation. Correspondingly, we recommend keeping the samples in buffer, if 
possible. Another benefit of keeping cells in buffer is that it allows for simple and 
fast tuning of the ON- and OFF-times by changing the reductant and oxidant 
concentrations in the buffer solution. 
 
Fluorophores 
 It is as important to choose an appropriate fluorophore and appropriate 
imaging and staining conditions, as it is to use a highly sensitive microscope. 
There are many options available in regards to choosing an appropriate 
fluorophore to use for imaging, but in general, commercially-available dyes (e.g. 
ATTO dyes) work well for use with Blink Microscopy.  
 
Antibody Labeling 
 As with other immunofluorescence-based labeling methods, a primary 
antibody must be carefully chosen to ensure both reliable specificity and affinity 
for the desired target molecule. It is best to directly label the primary antibody 
with the fluorophore, as this will lead to both less spatial distance between the 
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molecule of interest and the dye, and a simpler estimation of the number of dyes 
per target protein. Alternatively, if labeling the primary antibody is either 
technically difficult or results in altered binding to the target protein, sequential 
immuno-labeling with an unlabeled primary antibody and a labeled secondary 
antibody can be employed. Keep in mind, however, that this antibody complex 
can have a spatial extent of 10-20 nm, which may be a limiting factor when 
imaging very small structures, for example, quantifying nano-domain sizes.  
 
 Good protocols for labeling antibodies with fluorescent dyes are provided 
by the suppliers of reactive dyes, such as NHS-esters and maleimides. Our 
standard procedure for labeling with amine-reactive NHS-esters is as follows: 
 
1. Dissolve the protein in PBS at 0.5 – 1 mg/mL. 
2. Adjust the pH of a 250 µl antibody solution to be between 8.5 – 9. 
3. Dissolve 0.1 mg of dye in 10 µl of DMF, or another water-free solvent. 
4. Add 1 – 5 µl of dye solution to the antibody solution. Whole IgG molecules 
contain more amine groups and require more dye than, for example, Fab2 
fragments.  
5. Shake at room temperature for at least three hours. 
6. Remove excess dye using a desalting column (e.g. NAP-5, GE Healthcare). 
7. Determine the degree-of-labeling by absorption spectroscopy of the filtrate. 
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 For Blink Microscopy, it is best to have a low fluorophore number per 
target molecule. In part, this reduces the likelihood that more than one dye will be 
simultaneously emitting within the area of a point-spread function (PSF) of the 
dye. If more than one dye is emitting within a single PSF it is likely that the dyes 
will be rejected during image processing steps and not included in the final SR 
image, or will lead to a wrong localization. Both will worsen the quality of the 
final SR image. Additionally, more fluorophores within a small area may lead to 
physical contact between dyes, which can alter their photophysical properties and 
compromise Blink Microscopy. 
 
Cell Labeling 
 In order to generate an accurate SR image (without missing information 
from unlabeled target molecules) or to estimate the number of molecules from a 
SR image, it is important to label the structure of interest to saturation or as 
completely as possible. Saturation can be assured by immunostaining samples 
with increasing concentration of primary antibody (combined with an excess of 
labeled secondary antibody, for sequential immunostaining experiments). The 
concentration of the primary antibody should be increased until the fluorescence 
intensity of the structure, using identical acquisition settings for widefield 
microscopy, saturates. The lowest antibody concentration that achieves the 
maximum possible fluorescence intensity is then used for the experiments. For 
very dense structures, it is possible to label with antibody concentrations below 
saturation levels in order to achieve single-molecule localization during 
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acquisition. However, in this instance, it should be noted that the final SR image 
will not represent the complete structure, so the staining should occur at 
concentrations as close to saturation as possible. Of course, this labeling 
characterization only works with primary antibodies with high specificity for their 
target molecule. If antibodies bind non-specifically, the fluorescence intensity will 
saturate at much higher concentrations, where the non-specific fluorescence will 
outshine the actual signal. 
 
 Fixation and staining of cells will depend upon the particular cell type and 
target structure to be studied. Careful attention should be given to the choice and 
concentration of antibodies. As an example, the procedure for staining 
transmembrane proteins DC-SIGN and Dectin-1 on human dendritic cells is 
given: 
 
1. Wash cells 3 × with PBS.  Incubate cells in between washes to maintain cell 
health. 
2. Fix with 4 % PFA/PBS, by incubating at room temperature for 20 min. Note 
that depending on the structure to be visualized, cell permeabilization may be 
necessary. 
3. Wash cells 3 × with PBS. At this stage, cells can be stored in PBS w/ 0.05 % 
sodium azide at 4 °C for several weeks.  
4. Block by incubating 30 min or overnight in PBS + 0.1 % BSA. 
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5. Stain with 100 µl of the primary antibody for the first protein of interest (in 
this example, mouse monoclonal IgG2b specific for human protein DC-SIGN) 
for 20 min at room temperature with a concentration of ≈10 µg/mL in PBS + 
0.1 % BSA. 
6. Wash cells 3 × with PBS. 
7. Add 100 µl of the secondary antibody (in this example, goat anti-mouse 
ATTO655-Fab) at a concentration of ≈2 µg/mL in PBS w/ 0.1 % BSA.  
Incubate at room temperature for 15 min in the dark (covered with foil or in a 
drawer). 
8. Wash cells 5 × with PBS. 
9. If a second color is required, proceed as described in steps 10-14 below. 
Otherwise see step 15.  
10. Stain with 100 µl of the other primary antibody for the second protein of 
interest (in this example, goat polyclonal IgG specific for human protein 
Dectin-1) for 20 min at room temperature with a concentration of ≈10 µg/mL 
in PBS + 0.1 % BSA. 
11. Wash cells 3 × with PBS. 
12. Add 100 µl of appropriate secondary antibody for the second protein (in this 
example, rabbit anti-goat Alexa546). Incubate at room temperature for 15 min 
in the dark (covered with foil or in a drawer). 
13. Wash cells 5 × with PBS. 
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14. Store cells in 2 mL PBS, at 4 °C, sealed with parafilm and protected from 
light. 
15. Visualize with fluorescence for Blink Microscopy. 
 
3.4.2 Microscope Set-up 
A prerequisite for any super-resolution approach that is based on the localization 
of single molecules is the ability to detect single fluorophores with a good signal-to-noise 
ratio (SNR). This imposes an upper limit for the resolution that can be achieved for a 
given dye. It is also important to use a strong laser, combined with a fast camera, which 
can drastically reduce the image acquisition time and increase the achievable resolution 
by optimizing the ratio of ON-times to OFF-times. 
 
The task of breaking the diffraction barrier is not trivial and requires attainment of 
the highest detection efficiency, signal-to-noise ratio and optical resolution. Any trade-
offs made regarding the components of the microscope will certainly compromise SR 
image quality and resolution. 
 
Microscope Body 
Any microscope body that has an entrance for a laser light source and 
side-, front-, or bottom- port to attach an EMCCD camera can be used. An 
autofocus system is not necessary, however, it may be helpful if longer image 
acquisition times are required. Manual refocusing during the acquisition of a SR 
image introduces too many vibrations. 
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Light Source 
Blink Microscopy requires a relatively strong CW laser that has at least 
100 mW output power. This intensity is needed in order to drive the fluorophore 
into its dark radical form within milliseconds of illumination. An even higher-
powered laser may be beneficial if the light is coupled into an optical fiber, or if a 
large sample area is to be illuminated. 
 
Filters and Dichroics 
High-end filters and dichroics are essential to obtain a suitable signal-to-
noise ratio. For most solid-state laser sources, a clean-up filter is required to block 
non-peak wavelength light emitted by the laser. The dichroic should be specific 
for the chosen laser and be able to reflect >90% of the respective wavelength. The 
emission filter must have an OD = 6 in the range that the clean-up filter has an 
OD < 3. When multiple lasers are used, care must be taken that each emission 
filter can completely block each laser. Some filters tend to have low ODs in 
regions a few hundred nanometers away from their transmission window. 
 
Objective 
For sufficient magnification and collection efficiency, high-N.A. 
objectives with 60× or 100× magnification should be used. A numerical aperture 
of at least 1.4 is required for objective-based total internal reflection (TIR) 
microscopy, which offers a much better SNR than conventional widefield 
microscopy. 
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CCD-Camera 
For the detection of single molecules, each emitted photon is important. 
So the detection efficiency should be as high as possible. Back-illuminated 
EMCCD cameras are the most widely used, because they offer a quantum 
efficiency of >90% between 480 nm and 700 nm. A new generation of CMOS 
chips can acquire images much faster, but are currently only available in front-
illuminated versions that have quantum efficiencies around 50-60%. 
 
Optical Alignment 
Beam path optics are provided by the microscope manufacturers. If 
possible, the illuminated area should be set to an area as small as possible (yet 
sufficiently large to illuminate the desired field of view) in order to maximize 
illumination density. Depending on the camera’s physical pixel size, additional 
magnification in the detection path may be used to achieve an image pixel size 
between 80 nm and 140 nm. 
 
For later analysis it is essential to measure the effective image pixel size 
for each configuration (objective, additional magnification, and camera). For this 
purpose, stage micrometers with 10 µm line distances are commercially available.  
 
1. Mount the stage micrometer on the microscope and align it so that the lines 
appear vertical on the camera. 
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2. Count the number of lines (nlines) visible on the camera and determine the 
number of pixels (npx) between the outermost lines. 
3. The pixel size in nanometers is:  
€ 
nlines • 10,000 nm
npx
 
 
3.4.3 Does the Microscope Detect Single Molecules? 
 Before starting a SR measurement, make sure the microscope is working 
properly. This can be done by preparing a simple test slide with single fluorophores. 
 
1. Prepare a 5 mg / mL BSA solution. 
2. Incubate the BSA solution on a glass slide for 15 minutes. 
3. Wash the slide, mount it on the microscope, and add the labeled antibody used 
for imaging at a concentration of ≈ 10-8 M in the BSA solution. 
4. Incubate for 5 minutes and wash 2 × with the BSA solution (when imaging 
with a TIR microscope, the dye solution can remain on the slide, because the 
solution background should not be visible).  
5. Cool the camera to -55 °C, set the EM gain to 250, make sure the optics are 
set for TIRF illumination, and adjust the laser power to approximately 10 
µW/µm². 
6. Single molecules should be visible on the glass surface.  If too many 
molecules have bound, repeat with reduced concentration of labeled antibody 
and/or incubation time.  If there are no molecules visible, supplement the BSA 
solution used in the first step with some primary antibodies that will bind to 
the labeled secondary antibody. 
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7. Test for the presence of single molecules by continuously imaging with high 
laser intensity and observing single-step photobleaching, or count bleaching 
steps and compare to the expected dye-to-protein ratio calculated according to 
the degree-of-labeling of the secondary antibody. 
8. At this point an estimate for the localization precision can be obtained by 
recording the raw data and analyzing it as if it was actual Blink Microscopy 
data (see section on Post-Processing). The FWHM of the resulting spots in 
the super-resolution image reflects the expected resolution for the Blink 
experiment. 
 
3.4.4 Testing the Resolution with NanoRulers 
 To ensure that the microscope is not only able to detect single molecules, but is 
also able to perform super-resolution measurements, it is favorable to actually test for the 
ability to resolve sub-diffraction distances. Since 2011, there are commercially available 
calibration standards specifically for this purpose (www.sts-nano.com). 
 
 The resolution stated in many publications is based on experimental evidence 
from cellular structures. This approach is certainly not inaccurate, but may be hard to 
reproduce and depends on how long the researcher is willing to search for “the right 
structure”. This structure consists of two spots or lines at a distance large enough to be 
resolved and small enough to demonstrate the resolution advantage of using the 
respective method. A novel approach for creating nanoscale distance standards, based on 
DNA nanotechnology, can supply the required resolution test sample [24]. Based on the 
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DNA origami technique [31], fluorophores are placed at specific positions on a 100 x 70 
nm grid. Thousands of identical structures, all exhibiting a distance of, 80 nm, for 
example, can be immobilized on a glass surface and imaged with Blink Microscopy or 
other complimentary techniques. These standards, named “NanoRulers”, are easy to use 
without further technical knowledge and provide reliable information on the status of the 
microscope. 
 
3.4.5 Preparing the Dye to Blink 
 Depending on the fluorophore used, slightly different procedures are required to 
make the fluorophores blink in the right way for Blink Microscopy. Some exemplary 
procedures are listed below. They should be considered examples to act as a starting 
point for optimizing the respective conditions for each cell type and protein of interest. 
Details on how to fine-tune these conditions can be found in the section on Finding the 
Right Blink Parameters. 
 
Cyanine Dyes (e.g. Cy3b and Cy5 [6]) 
 Cy5 is widely used in fluorescence imaging. Previous SR imaging 
techniques like STORM [2] and dSTORM [8] were first demonstrated with this 
fluorophore, but rely on a different mechanism [32, 33]. The mechanism of Blink 
Microscopy requires the fluorophore to be reduced from an excited state, forming 
a radical anion. As in STORM and dSTORM, oxygen must be removed, as it acts 
as a triplet quencher and oxidant. This can easily be done enzymatically as 
described in the literature [34, 35]. Also, the absence of oxygen drastically 
increases the photostability of the dye. 
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1. Prepare an AA working solution by diluting the 100 mM stock 1:10 in PBS. 
2. Fill 95 % of the LabTek chamber, containing cells that have been stained (as 
in the section on Cell Labeling), with PBS containing 1 % glucose (700 µl). 
3. Add 7 µl of AA working solution. 
4. Add 35 µl of oxygen scavenging solution, which should completely fill the 
chamber. 
5. Mix quickly (by pipetting up and down) and seal chamber using sealing 
sheets.  
6. Wait approx. 5 – 10 minutes, until oxygen is removed (see Notes 2 and 3). 
 
Oxazine Dyes (e.g. ATTO655 [22]) 
 Due to the relatively low energy level of the radical anion of ATTO655, 
its reduced state is remarkably stable, even in the presence of oxygen. Because of 
this, oxygen removal is not required to obtain sufficiently long OFF-times for 
Blink Microscopy. To prevent photobleaching, however, oxygen can be removed 
and the OFF-times adjusted by addition of an alternative oxidizing agent, e.g. 
methyl viologen. 
 
 Another characteristic feature of ATTO655 is that the number of photons 
emitted can be tuned by varying the concentration of AA. High photon numbers 
offer the advantage of higher localization precision, but at the cost of imaging 
speed and vice versa. The ideal parameters for each type of experiment are found 
empirically [22]. 
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1. Prepare a working solution of AA by diluting the 100 mM stock 1:10 in PBS. 
2. Fill 95 % of the LabTek chamber with PBS (containing 1 % glucose if oxygen 
removal is required). 
3. Add 7 µl of AA working solution. 
4. Note: No oxygen removal is required. 
5. Note: Optimize Blink parameters as discussed in the section on Finding the 
Right Blink Parameters. 
 
Other Dyes 
 Many other dyes can potentially be used for Blink Microscopy. We found 
the fluorophore Alexa 546 to work with the same parameters as given for 
ATTO655 in the previous section. It may be helpful to also try other reducing 
agents, like the thiols mercaptoethylamine (MEA) or beta-mercaptoethanol (ME), 
if ascorbic acid does not show the desired effect (see dSTORM, ref [26]). In the 
case of thiols, the reducing species is the thiolate, which means that thiols are 
used at higher concentrations and reproduced through the acid-base equilibrium. 
For thiols, however, the pH has to be carefully controlled, since the effective 
thiolate concentration is strongly pH dependent. 
 
3.4.6 Finding the Right Blink Parameters [36] 
 In a first step, acquire 2000 frames at the fastest camera integration time (≈4 ms) 
and highest laser power (≈200 mW). Discard the first 10 – 200 frames, when too many 
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dye molecules are still in their ON-state. Browse through the raw data looking at 
individual frames.  
 
 It is essential that the raw data is of good quality, exhibiting single-molecule blink 
events with a good SNR. The following sections should help to identify possible error 
sources and eliminate them.  
 
Check for Single Molecule Events 
 When looking at consecutive frames, diffraction limited spots should be 
identified. They must be perfectly circular (within the limit of the pixel size), 
uniform in brightness, and appear and disappear within one or two frames. If all 
spots appear asymmetric or elliptical in the same way, microscope detection 
optics should be checked. Otherwise, the dyes are not blinking properly and 
multiple spatially-distributed emitters are forming an asymmetric emission 
pattern.  
 
Laser Intensity / ON-times 
 Assuming one is imaging with the highest laser intensity possible and has 
succeeded in imaging single-molecule events, look at individual fluorescent 
regions over time. Most Blink events (ON-times) should have a length of 1 – 3 
frames. Consider that ON-times are distributed exponentially. 
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1. If the majority of events exhibit ON-times of 3 or more frames, the laser 
intensity can be increased. Alternatively, the ON-times of dyes like 
ATTO655 can be reduced by adding higher amounts of a reducing agent. 
If both these measures are not feasible or sufficient, a longer ON-time is 
acceptable in the case that the OFF time is sufficiently long and/or the 
sample is not too densely labeled. 
2. If all or almost all fluorescent events occur within just one frame, meaning 
fluorescence starts in one frame and is no longer detected in the next 
frame, the laser power is set too high and should be decreased until a 
distribution of ON-times, as described above, is obtained. 
 
OFF-times 
 For localization-based super-resolution microscopy to work, Blink events 
from individual molecules within a diffraction-limited area must be separated in 
time. In principle, just one dark frame in between two Blink events is sufficient, 
however, the exponential distribution of OFF-times makes it necessary to have a 
cumulative average OFF-time of at least a few frames. This cumulative OFF-time 
is the time while all molecules within the area of one diffraction limited spot are 
in their dark state, and is the cumulative effect of a stochastic distribution of the 
OFF-times of all single emitters. 
 If fluorescence events are not separated by several dark frames, try 
adjusting (decreasing) the oxidizing agent concentration. Alternatively, if the 
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DOL of the secondary antibody is greater than two, re-labeling of the antibody 
with a lower dye concentration is recommended. 
 
Camera Integration Time and Laser Intensity 
 According to ref [36], the camera integration time is ideally set to equal 
approximately twice the average ON-time of a single fluorophore. In most cases, 
the fastest possible recording time (5 – 10 ms) is desired, as this minimizes drift 
effects. Depending on whether the camera speed or the laser power is the limiting 
factor, the other must be adjusted to obtain optimal resolution. To increase the 
camera frame rate, a subset of the CCD pixels can be read out to achieve faster 
acquisition. This is especially applicable when using TIRF illumination, which 
often does not excite the whole field-of-view.  
 
3.4.7 Data Collection 
Software 
 The collection of data is relatively uncritical, and therefore there is a large 
range of feasible possibilities. One of the simplest possibilities is the use of the 
software supplied by the camera manufacturer, combined with subsequent 
analysis in a separate software program. More elegantly, one could use highly 
integrated software that controls the whole microscopy system and integrates live 
display of the super-resolution image as it is recorded. This software is usually 
provided with commercial microscopes. 
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Camera Settings 
1. Cool the camera to -55 °C; this can take a few minutes. 
2. Enable EM gain and set it to 250 (see Note 4). 
3. Enable frame transfer mode.  This is an important setting. Otherwise there 
will be pauses for CCD readout between the camera frames. Photons 
emitted during this time will not be detected (up to 80 %). 
4. Set the camera integration time (see the section on Camera Integration 
Time and Laser Intensity). 
 
Recording Raw Data 
1. The laser should run at the full power used for SR imaging. When imaging 
to find the structure of interest and adjust the focus, the laser should be 
attenuated to about 5 mW to avoid introducing significant photobleaching.  
2. It has proven practical to use a fast remote-controlled shutter to protect the 
sample from photodamage while removing (or adjusting) the attenuator. 
3. Before opening the shutter, image acquisition should be started to collect 
some dark frames. This has the advantage that when the shutter is opened, 
an image is acquired where all fluorophores are still in their active state. 
This resembles a standard wide field image that can subsequently be 
compared to the SR image. 
4. Images can be acquired until no more fluorophores are active (complete 
photobleaching has occurred).  
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Post-Processing 
 As the raw data of a SR image is a stack of thousands of diffraction-
limited images, the information of each frame must be extracted and combined 
into a single graph. There are several approaches that differ in speed, accuracy, 
and their level of corrections. If you are using a custom-built microscope, there 
are several programs freely available on the internet [9, 37, 38]. Usually, in a first 
step, single-molecule Blink events are identified. In this step, algorithms can be 
applied that exclude emission from multiple molecules, which are identified by 
shape or intensity. Second, the identified spots are fit to a two-dimensional 
Gaussian function. The most straightforward approach utilizes a least-square fit. 
This yields very accurate results, but is relatively time consuming. Simpler 
alternatives involve the centroid-finding functionalities included in most 
programming environments, e.g. LabView, Igor, or Matlab. Faster, more 
specialized algorithms, are developed constantly [39]. 
 
 As an example, a set of Blink Microscopy data was analyzed with three 
different software packages that are freely available (see Figure 2.3).  The 
software available from the publication of DNA-PAINT [9], the built-in Igor 
localization algorithm, and the ImageJ-plugin named quickPALM [38] were 
employed using standard settings. For better comparison, molecule coordinates 
were exported and plotted in Origin. This comparison is not meant to identify “the 
best” software, or to give a comprehensive overview of what is available, but to 
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show that the choice of data analysis software may have an influence on the 
interpretation of SR data. 
 
3.5 NOTES 
 
1. What is the Resolution, Actually?  One of the most important and probably most 
asked questions about super-resolution microscopy is: “what is the best resolution one 
can get?”. Each publication on a new SR method claims to achieve a number as low 
as possible, and this claim is generally supported by using an experimental example. 
However, it is hard to predict the resolution limit of a particular experiment in 
advance [40].  In practice, determining the achieved resolution limit will require 
finding and imaging very small structures that are at or below the resolution limit of 
the experiment (see discussion in section on Microscope Set-up).  Additionally, there 
are several aspects relating to the conditions used for labeling that can further limit or 
enhance the achievable resolution.  The first resolution-limiting factor, relating to the 
density and size of the label, is independent of the imaging method chosen. In 
general, the higher the degree of labeling, the more detail can be resolved in an 
image. Therefore, the labeling of the sample must be sufficiently high to show the 
required amount of detail for the desired resolution. Once again, quoting Nyquist in a 
different context [41], the labeling density must be at least twice the resolution of the 
image. In practice, if one wants to discern two objects at a distance of 10 nm, there 
must be room for a fluorescent label every 5 nm or less. Speaking in a simplified, 
descriptive way, there must be room for a gap (or label) between the two objects. 
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When using indirect immunostaining methods (using primary and secondary 
antibodies), the achievable resolution may be limited to >30 nm, because the 
antibodies are generally 5-15 nm in size. This is one of the reasons why we prefer 
using Fab2 fragments over whole IgGs. 
 
   Secondly, the resolution of localization-based microscopy indirectly 
depends on the labeling density, the number of fluorophores per diffraction-limited 
area. If a structure is densely-packed, there is a higher probability that there will be 
more than one dye in an ON- state within a diffraction-limited area than if the same 
number of dyes are diffusely spread over a larger area.  If a software program 
attempts to fit a diffraction-limited spot that contains more than one dye, false 
localizations may be present in the final SR image and the overall resolution of the 
SR image will be decreased [36]. Increasing the OFF-times of the dyes will 
effectively decrease the labeling density because it will reduce the number of dyes 
that are emitting in a PSF at a given time. Therefore, imaging a densely-packed 
structure requires longer OFF-times than when imaging a diffusely-spread signal.  In 
practice, this means that longer OFF-times are required when imaging a densely-
packed cluster of proteins than when imaging a cytoskeleton protein that is diffusely 
located along a filament [40]. In this manner, the resolution obtained in one published 
experiment is not necessarily what can be achieved in a different context. 
 
2. If there is more than a small bubble of air in the chamber, increase all volumes 
proportionally. 
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3. There is no need for an oxidizing agent, as cyanine dyes switch on spontaneously by 
the remaining oxygen.  
 
4. All current EMCCD cameras offer a linear gain in the range of about 1 – 1000. If 
your camera gain cannot be set to 250, set it to the highest possible value. 
 
5. It’s a graph, not an image. The output of the software described in the section on 
Post-Processing reports fluorophore coordinates in a double precision floating-point 
format (e.g. x = 31.23589062, y = 9.14215860). Each coordinate by itself is zero-
dimensional, so it does not occupy any space in an image. The pixels in a SR image 
are created by binning the number of localizations within a certain area (e.g. 10 µm 
divided into 10 nm pixels). The size of these bins can be chosen arbitrarily and 
changed in post-processing without loss of information. However, the more important 
question is: What binning is actually reasonable? According to the sampling theorem 
of Nyquist [41], the bin size must be at least half the expected resolution of the 
method. For a resolution of 20 nm, then, the recommended pixel size is somewhere 
between 5 – 10 nm. Fig. 4 shows a particular structure binned in 30, 10 and 3 nm 
pixels. Choosing the bins too large (left) makes it impossible to determine the 
substructure in the example. The center binning reveals a structure in the area of 
interest. When the bins are chosen too small (right panel), mostly single pixels are 
visible, which do not form an image easily perceived by the eye. The pixel size must 
therefore be chosen carefully, particularly when automatically analyzing SR images 
to determine cluster sizes. This should actually be done not on a SR image, but 
directly on the localization coordinates with specialized algorithms. 
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3.6 FIGURE LEGENDS 
 
Figure 3.1. An example of Blink Microscopy data from filamentous actin on a glass 
surface (reproduced/adapted with permission from ref. [36], doi: 10.1007/978-90-
481-9977-8_5). Left: At the beginning, all fluorophores are in their ON state. This 
ensemble of fluorescent molecules provides a diffraction-limited image. Center: The 
excitation laser quickly drives all molecules into their OFF-state while individual 
molecules switch back ON and can be localized as single-molecule events with high 
precision. This step is at the heart of Blink Microscopy and most experimental parameters 
described in this chapter aim at optimizing this single-molecule blinking. Right: all found 
localizations are binned into a super-resolved image. 
 
Figure 3.2. Dark state reactions used for Blink Microscopy (reproduced/adapted 
with permission from ref. [16], doi: 10.1002/cphc.201000189). a) Jablonski diagram 
showing the photophysical states of a single fluorophore. The driving force behind the 
OFF-switching reaction is provided by fluorescence excitation (kexc), followed by 
occasional intersystem crossing (kISC) and reduction by a reductant in solution (kRed). The 
fluorophore switches back ON due to oxidation by oxygen or an added oxidant (kOx). 
Note that there is no need for a separate switching laser and that the reaction is fully 
reversible, so that each dye can run through many ON-OFF cycles. b) Fluorescence vs. 
time transient showing several switching cycles of a single fluorophore. 
 
Figure 3.3. Blink Microscopy data analyzed with different software programs.  a) 
An example of the localization of the protein DC-SIGN on fixed human dendritic cells 
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following sequential immunostaining (with DCN46, Invitrogen, and ATTO655-Fab, 
ATTO-TEC) and imaging with Blink Microscopy. The standard TIRF image is shown in 
green, overlaid with red SR data. The cell boundary is indicated by a red line. A subset of 
SR raw data was analyzed with b) DNA-PAINT software, c) quickPALM software and d) 
the IGOR standard spot finding algorithm. Each dataset was plotted in Origin to obtain 
comparable graphical output (unbinned, non-convoluted spot positions). Scale bars are 
1µm. 
 
Figure 3.4.  Effects of bin size on SR image appearance. SR data binned in 30, 10 and 
3 nm pixels (left to right). 
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FIGURE 3.1 
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FIGURE 3.2 
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FIGURE 3.3 
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FIGURE 3.4 
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CHAPTER 4 
DC-SIGN and Influenza Hemagglutinin Dynamics in Plasma Membrane 
Microdomains are Markedly Different1 
 
4.1 SUMMARY 
 
 DC-SIGN, a Ca2+-dependent transmembrane lectin, is found assembled in 
microdomains on the plasma membranes of dendritic cells. These microdomains bind a 
large variety of pathogens and facilitate their uptake for subsequent antigen presentation. 
In this paper, DC-SIGN dynamics in microdomains have been explored with several 
fluorescence microscopy methods and compared with those for influenza hemagglutinin 
(HA), which is also found in plasma membrane microdomains. Fluorescence imaging 
indicated that DC-SIGN microdomains may contain other C-type lectins and that the DC-
SIGN cytoplasmic region is not required for microdomain formation. FRAP 
measurements showed that neither full-length nor cytoplasmically truncated DC-SIGN in 
microdomains appreciably exchanged with like molecules in other microdomains and the 
membrane surround, whereas HA in microdomains exchanged almost completely. Line-
                                                 
1 Reproduced/adapted with permission from: 
Itano MS, Neumann AK, Liu P, Zhang F, Gratton E, Parak WJ, Thompson NL, Jacobson 
K, 2011.  Dynamics of DC-SIGN and influenza hemagglutinin in microdomains on 
plasma membranes, Biophysical Journal, 100(11):2662-70.  
doi: 10.1016/j.bbr.2011.03.031 
 
Michelle S. Itano contributed to all of the Figures in the manuscript, and was also the 
primary contributor to the overall organization, writing and editing of this manuscript. 
Aaron K. Neumann contributed to Figures 4.1 - 4.3 and Supplemental Figure 4.1. Ping 
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scan FCS indicated an essentially undetectable lateral mobility for DC-SIGN but 
appreciable mobility for HA within their respective domains. SPT with defined valency 
quantum dots confirmed that HA has significant mobility within microdomains, whereas 
DC-SIGN does not. By contrast, FRAP indicated that inner leaflet lipids are able to move 
through DC-SIGN microdomains. The surprising stability of DC-SIGN microdomains 
may reflect structural features that enhance pathogen uptake either by providing high-
avidity platforms or by protecting against rapid microdomain endocytosis.  
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4.2 INTRODUCTION 
 
 Immature dendritic cells are highly endocytic professional antigen presenting 
cells that recognize pathogen associated molecular patterns (PAMPs) to mediate antigen 
acquisition [1, 2]. Antigen recognition is facilitated by calcium-dependent antigen-
capture receptors, called C-type lectins, that bind to high mannose structures present on 
the surfaces of numerous pathogens including viruses, bacteria, yeast and parasites [3, 4]. 
One C-type lectin abundantly expressed on immature dendritic cells is DC-SIGN 
(dendritic cell-specific intercellular adhesion molecule-3-grabbing non-integrin), also 
termed CD209. Other C-type lectins are also found on immature dendritic cells, including 
dectin-1 and macrophage mannose receptor (MMR, or CD206). The molecular details 
through which these transmembrane receptors mediate pathogen uptake are at present not 
fully understood. The work described in this paper focuses primarily on DC-SIGN. 
 
 DC-SIGN is thought to exist as a tetramer in the plasma membrane through 
interactions of the extracellular repeat domains of the protein [5-7]. Transmission 
electron microscopy and near-field scanning optical microscopy studies have determined 
that DC-SIGN molecules (presumably in the form of tetramers) in fixed cells are found in 
distinct protein microdomains on the nanometer scale [8-10]. More recently, the 
distribution and dynamics of DC-SIGN microdomains on the plasma membranes of live 
dendritic cells were examined by using wide field and confocal fluorescence microscopy 
techniques [11]. The clustering of DC-SIGN is required for efficient pathogen binding 
and internalization [8]. DC-SIGN clustering increases binding avidity, which may 
improve binding to small or multivalent ligands. The particular molecular interactions 
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that mediate the clustering of DC-SIGN have not yet been determined and, furthermore, 
the dynamics of DC-SIGN molecules within microdomains have not been investigated. 
 
 In this chapter, we describe our findings regarding the dynamics of the general 
pathogen receptor DC-SIGN, and compare the dynamics to those of the well-studied 
influenza hemagglutinin (HA). We find that DC-SIGN in microdomains is partially co-
localized with dectin-1, MMR and clathrin. Multiple fluorescence microscopy techniques 
indicate that DC-SIGN is essentially immobilized in microdomains and that this stability 
is not dependent on the cytoplasmic tail of DC-SIGN. These findings contrast with HA, 
which also forms microdomains on the plasma membrane, but is laterally mobile within 
and outside microdomains and exchanges between these two regions. Although DC-
SIGN shows no appreciable mobility within microdomains, lipids are free to move 
through these small regions. Taken together, our results strongly suggest that 
microdomains containing DC-SIGN have a complex, unexpected underlying molecular 
structure. 
 
4.3 MATERIALS & METHODS 
 
Cells 
 Human monocyte-derived immature dendritic cells were prepared from human 
whole blood obtained from the New York Blood Center (Long Island City, NY) as 
previously described [11]. Peripheral blood mononuclear cells were isolated from the 
blood by centrifuging over a Ficoll gradient (Ficoll-Paque PLUS, GE Healthcare, 
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Uppsala, Sweden) and resuspended in Dulbecco’s phosphate-buffered saline (DPBS, 0.08 
M sodium phosphate, 0.14 M NaCl, pH 7.4, GIBCO, Grand Island, NY) with 0.5 % (w/v) 
bovine serum albumin (BSA, Santa Cruz Biotechnology, Santa Cruz, CA). Monocytes 
were culled from the peripheral mononuclear cells by adherence to tissue culture flasks 
for 2-3 hours followed by washing with RPMI-1640 medium containing 10% fetal bovine 
serum (FBS). After approximately 24 hours detached cells were replated on glass-bottom 
MatTek dishes (MatTek Corp., Ashland, MA) with RPMI-1640, 10 % FBS, 500 U/mL of 
human IL-4 and 800 U/mL of human GM-CSF (Peprotech, Rocky Hill, NJ) to stimulate 
development of immature dendritic cells.  
  
 Three types of NIH 3T3 mouse fibroblasts permanently expressing different 
versions of human DC-SIGN were used. NIH 3T3 cells do not endogenously express 
mouse DC-SIGN [11]. The MX-DCSIGN cell line, originally generated by Drs. Thomas 
D. Martin and Vineet N. KewalRamani [12], was obtained through the NIH AIDS 
Research and Reference Reagent Program, Division of AIDS, NIAID, NIH. The Δ35-
MX-DCSIGN and Δ20-MX-DCSIGN cell lines were made by using NIH 3T3 cells, 
plasmids encoding human DC-SIGN with either 35 or 20 amino acids truncated in the 
cytoplasmic region, respectively (a generous gift from Dan Littman, New York 
University and Howard Hughes Medical Institute, New York, NY), and the Phoenix-ECO 
retroviral packaging system (ATTC product# SD 3444) following the Phoenix-Helper 
dependent protocol (http://www.stanford.edu/group/nolan/protocols/pro_helper_ 
dep.html). All three cell types were propagated in culture using the medium 
recommended for MX-DCSIGN, high glucose DMEM with 10 % FBS.  
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 For the lipid FRAP experiments, DC-SIGN and a monomeric red fluorescent 
protein targeted to the inner leaflet of the plasma membrane (PMT-mRFP), were co-
expressed in NIH 3T3 cells. The PMT-mRFP construct, kindly provided by Ichiro 
Maruyama (Genome Institute of Singapore, Singapore), contains the consensus sequence 
for N-myristoyl transferase and one site for the attachment of a palmitoyl moiety [13]. 
Previous work and our observations (data not shown) indicate that the protein product is 
mainly restricted to the plasma membrane [13, 14]. First, the DC-SIGN gene was 
amplified by polymerase chain reaction (PCR) from the pMX-DCSIGN vector (as 
obtained through the AIDS Research and Reference Reagent Program, Division of AIDS, 
NIAID, NIH, originally generated by Dr. Douglas Kwon and Dr. Dan Littman) with 
primers encoding EcoR I and Sal I sites (underlined), respectively: 5’ –CCGGAATTCCA 
TGAGTGACTCCAAGGAACCAAGA and 5’ –CAAGACGTCGACCTACGCAGGAG 
GGGGGTTTGGGGT. The PCR product was then digested with EcoR I and Sal I, and 
cloned into a modified pEGFP-C1 vector (Clontech, Mountain View, CA), kindly 
provided by Cai Huang (University of Kentucky, Lexington, KY), in which the EGFP 
gene was removed. The construct was confirmed by DNA sequencing. For the co-
expression of DC-SIGN and PMT-mRFP, the ratio of the amounts of the two plasmids 
was kept at 1:1 (2 µg DC-SIGN/2 µg PMT-mRFP per dish). NIH 3T3 cells were seeded 
in 35 mm glass-bottom dishes (MatTek) in high glucose DMEM with 10 % FBS one day 
before transfection, and the mixture of the two plasmids were introduced into the cells by 
following the standard Fugene 6 protocol (Roche, Indianapolis, IN). Two days after 
transfection, cells were first stained by DCN46 (BD BioSciences, 10 µg/mL) for 15 min 
and followed by secondary goat anti-mouse Alexa488-conjugated IgG (Invitrogen, 1 
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µg/mL) for 5 min at 37 °C in an incubator. The cells were then washed thoroughly with 
DPBS, and covered with DPBS during the observation on the microscope. FRAP 
measurements were carried out at room temperature as described later in detail.    
 
 An NIH 3T3 cell line (called HAb2) that permanently expresses HA from the 
Japan strain of influenza was obtained from Judith White (University of Virginia, 
Charlottesville, VA). These cells were maintained in culture using high glucose DMEM 
with 10 % FBS. 
 
Antibodies 
 Most antibodies were obtained commercially, as follows: mouse monoclonal 
IgG2b specific for human DC-SIGN (DCN46; BD Biosciences, San Jose, CA), rabbit 
polyclonal IgG specific for human DC-SIGN (H-200; Santa Cruz Biotechnology), goat 
polyclonal IgG specific for human dectin-1 (AF1859; R&D Systems, Minneapolis, MN), 
goat polyclonal IgG specific for human CD206 (MMR) (AF2534; R&D Systems), mouse 
monoclonal IgG2b specific for clathrin light chain from a variety of species (CON.1; 
Santa Cruz Biotechnology), Alexa568-conjugated and Alexa488-conjugated goat 
polyclonal antibodies specific for mouse IgG (Invitrogen), Alexa488-conjugated donkey 
polyclonal antibodies specific for goat IgG (Invitrogen), Alexa488-conjugated donkey 
polyclonal antibodies specific for rabbit IgG (Invitrogen), biotinylated, rat monoclonal 
IgG2a specific for human DC-SIGN (eB-h209; eBioscience, San Diego, CA), and 
biotinylated, mouse monoclonal IgG1 specific for HA (HA-7; Sigma-Aldrich, St. Louis, 
MO). According to the manufacturers, fluorescent antibodies contained approximately 5-
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7 fluorophores per protein and biotinylated antibodies contained approximately 3-7 biotin 
moieties per protein. 
 
 Two antibodies were prepared in-house. The mouse hybridoma DC6, which 
secretes IgG1 specific for human DC-SIGN [15], was a gift of Robert Doms (University 
of Pennsylvania, Philadelphia, PA). The mouse hybridoma FC125, which secretes IgG2a 
specific for human HA [16], was obtained from Thomas Braciale (University of 
Virginia). In both cases, hybridomas were grown in PFHM-II protein-free hybridoma 
medium (GIBCO). DC6 and FC125 IgG were purified from hybridoma supernatants by 
Protein A affinity chromatography (Pierce Biotechnology, Rockford, IL). The column 
was sequentially washed with 100 mM and 10 mM Tris at pH 8.0 and eluted with 50 mM 
glycine at pH 3.0. Eluates (1-4 mL) were immediately neutralized with 1 M Tris (pH 
8.0), concentrated by using spin columns (Ultracel-10k; Millipore, Billerica, MA) and 
dialyzed with Slide-A-Lyzer cassettes (Pierce Biotechnology) against 4 L PBS (diluted 
from PBS, 10×, Cellgro, Manassas, VA). For the line-scan FCS and the single-color 
FRAP experiments, these antibodies were conjugated with Alexa488 (Invitrogen), and 
the fluorophore to IgG ratio was estimated to be 0.7 according to the manufacturer’s 
protocol.  
 
Sample Preparation 
 In all cases, cells were plated in 35 mm glass-bottomed microscopy dishes 
(MatTek) in the appropriate medium. At the time of observation, cells were treated 
differently, such as fixed or permeabilized, depending on the measurement of interest as 
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described below. For all experiments the cells were always washed with PBS or media, 
and immersed in the appropriate medium not containing phenol red before imaging. 
 
Co-Localization Measurements 
 Immature human dendritic cells were fixed by using paraformaldehyde solution [4 
% (w/v) in PBS, pH 7.4] for 20 minutes at 25 °C. For measurements probing clathrin co-
localization, cells were then permeabilized with PBS containing 0.01 % Triton-X-100 for 
5 minutes at 25 °C. Fluorescence labeling was carried out by treating with primary 
antibodies (10 µg/mL), washing with medium, treating with fluorescent secondary 
antibodies (1 µg/mL), and then final washing. For the dectin-1 and CD206 
measurements, the primary antibodies were goat polyclonal IgG specific for human 
dectin-1 and CD206, respectively, and the secondary antibodies were Alexa488-
conjugated donkey polyclonal IgG specific for goat IgG. In these measurements, DC-
SIGN was labeled with DCN46 followed by Alexa568-conjugated anti-mouse IgG. For 
the clathrin measurements, the primary antibodies were CON.1 and H-200, for clathrin 
and DC-SIGN, respectively, and the secondary antibodies were Alexa568-conjugated 
goat polyclonal IgG specific for mouse IgG and Alexa488-conjugated donkey polyclonal 
IgG specific for rabbit IgG, respectively. 
 
 Epifluoresence imaging was carried out on a dual-channel Olympus IX81 inverted 
microscope equipped with a 60× oil immersion, 1.4 N.A. objective and a 100 W Hg arc 
lamp. Filters and dichroic mirrors (Chroma Technology Corp., Rockingham, VT) for 
Alexa488 and Alexa568 imaging were as follows: Alexa488, excitation, 488/10, 
 
 
67 
emission, 535/25; Alexa568, excitation, 535/50, emission, 610/75. Images were captured 
using an air-cooled SensiCam QE CCD camera (Cooke Corp., Romulus, MI) driven by 
Metamorph (Molecular Devices/Meta Imaging, Downingtown, PA). 
 
 For percent co-localization analysis, domains were first identified using ImageJ as 
follows. A “cell area mask” was created by thresholding the original image at a value 
intermediate to non-cell and cell area backgrounds. The cell area mask was then used to 
exclude (set to zero intensity) all pixels from non-cell area regions thus creating the “cell 
area image”. The cell area image was thresholded at the maximum intensity minus 1 
standard deviation to remove background (autoflourescence of the cell), identify domain 
areas and create the “cell area domains image”. An “eroded cell area mask” was created 
by applying the erosion function (single pixel width, ten iterations) to the cell area mask. 
Edge artifacts were avoided by multiplying the cell area domains image and the eroded 
cell area mask to create the “eroded cell area domains image”. A watershed filter was 
then applied to the eroded cell area domains image to separate adjacent domains. The 
domains were then identified using the Particle Analyzer (1-200 pixels, 0.500-1 
circularity) and output as a mask to generate the “final domains image” for each protein 
interrogated in the original images. The area of co-localization was determined by 
applying the logical ‘AND’ to the final domains images of two proteins to be compared. 
The logical ‘OR’ operation was used on the same images to determine the total domain 
area for both proteins. The percent co-localization was then calculated by taking the 
‘AND’ area divided by the ‘OR’ area for each image pair. 
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 In order to determine whether the co-localization was above what would be 
expected for two overlapping random distributions, a Ripley’s-K bivariate analysis was 
applied. The final domains images were cropped to exclude cell boundaries and their 
centroids were identified using the Particle Analyzer. The centroids were used as input 
for the Cellspan software (University of New Mexico, New Mexico) to perform ‘Ripley’s 
K for bivariate data’ analysis. Output is provided in the form of the L function, L(t)-t, as 
previously described [17]. This function transforms Ripley’s K function to a form where 
L(t)-t=0 for random distributions at all length scales (t). When L(t)-t (black line) is within 
the confidence interval for randomness (i.e., between the red lines), this indicates a 
random distribution. L(t)-t greater than the randomness confidence interval indicates 
clustering on the length scales denoted on the x-axis of the graph. 
 
Domain Imaging 
 MX-DCSIGN, Δ35-MX-DCSIGN, Δ20-MX-DCSIGN, and HAb2 cells were 
fixed by using PBS with 4 % (v:v) paraformaldehyde for 20 minutes at 25 °C. Cells were 
then fluorescently labeled by using primary and secondary antibodies as described above. 
The primary antibodies were either DCN46 or FC125 and the secondary antibodies were 
Alexa488-conjugated goat anti-mouse IgG. Images were acquired as described above for 
the green (Alexa488) channel. 
 
Fluorescence Recovery After Photobleaching (FRAP) 
  Measurements were carried out on live cells. MX-DCSIGN and Δ35-MX-
DCSIGN cells were labeled with 50 µg/mL Alexa488-conjugated DC6 for 5 minutes at 
 
 
69 
37 °C. HAb2 cells were labeled in the same manner with Alexa488-conjugated FC125. 
NIH 3T3 cells containing PMT-mRFP were fluorescent in the red channel as a 
consequence of the transfection and were labeled with DCN46 followed by Alexa488-
conjugated goat polyclonal IgG specific for mouse IgG for the purpose of identifying the 
locations of DC-SIGN domains.  
 
 Measurements were carried out on an upright Olympus FV1000 confocal 
microscope equipped with a live cell chamber and a LUMPL FL 60× W/IR 0.90 N.A. 
water immersion objective or, for the lipid FRAP experiments, on an inverted Olympus 
FV1000 equipped with a live cell chamber and a 60× 1.42 N.A. oil immersion objective. 
The 488 nm line of the argon ion laser was used for the Alexa488 excitation and the 559 
nm diode laser was used to excite the mRFP, with the laser power set between 0.1 and 5 
% according to the power slider in the FV1000 microscope software, for monitoring pre- 
and post-bleach fluorescence intensities. The variable slit had a nominal bandwidth of 
500-545 nm for the green emission channel and 590-650 nm for the red emission 
channel. Circular regions of interest (ROI) consisting of small areas on cell membranes 
containing individual domains were selected by using the green channel and the tornado 
scanning feature contained in the FV1000 software. These regions typically ranged from 
1.2 to 3.4 µm in diameter. Larger, square areas with sides ranging from 13 µm to 66 µm 
and surrounding the smaller, selected circular regions were imaged during the course of 
the experiment. Circular regions surrounding individual domains were bleached by using 
either the 488 nm (for HA, full-length DC-SIGN and Δ35-DC-SIGN) or 559 nm (for 
PMT-mRFP) beam at 100 % power for 300 ms or 150 ms, respectively. Bleaching was 
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carried out to ~ 50 % completion so that the partially bleached domains could still be 
tracked. 
 
 FRAP data were analyzed as previously described [18]. For the analysis, three 
circular ROIs were defined within the larger, square areas that were used for image 
acquisition (see above). The first ROI (hereby referred to as ROI1) was the same ROI as 
was used to define the bleached area for the tornado scan, and therefore was used to 
define the region containing the domain that was bleached during the experiment. The 
second ROI (hereby referred to as ROI2) was placed in a region not occupied by the 
fluorescent cell and was used to define the contribution of background intensity during 
the experiment. The third ROI (hereby referred to as ROI3), with the same dimensions as 
ROI1, was placed around a nearby unbleached domain. The mean intensities from ROI1, 
ROI2 and ROI3 as functions of time are denoted as Araw(t), B(t) and Craw(t), respectively. 
First, the raw fluorescence data from Araw(t) and Craw(t) were background corrected by 
subtracting B(t). Therefore, the mean intensities following background subtraction A(t) 
and C(t) were calculated as follows: A(t) = Araw(t) - B(t) and C(t) = Craw(t) - B(t). Next, 
the recovery data were adjusted to correct for the effects of photobleaching during pre-
bleach and post-bleach observation. The data were adjusted in the following way: F(t) = 
A(t)[C(-)/C(t)], where C(-) was the average pre-bleach intensity (acquired before the 
bleaching tornado scan). The % recovery was calculated by using the expression  
P(t) = 100[F(t)-F(0)]/[F(-)-F(0)], where F(-) was the pre-bleach fluorescence and F(0) 
was the fluorescence immediately after bleaching. The function P(t) was fit to the 
phenomenological expression, P(t) = P∞[1-exp(-kt)], with P∞ and k as free parameters, 
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using Igor Pro 6.0 (Wavemetrics, Portland, OR). From the fit, the values of P∞ were taken 
as mobile percentages and the values of k were used to calculate recovery half-times as 
τ1/2 = k-1 ln(2). The recovery times, τ1/2, for HA and the PMT-mRFP ranged from 2 s to 
100 s and from 0.3 to 1.7 s, respectively. Apparent diffusion coefficients were calculated 
from τ1/2 by using the equation: D = ρ2/(4τ1/2), where ρ denotes the radius of ROI1 which 
is the radius of the bleached area. Other more nuanced methods for analyzing confocal 
FRAP data have been developed (e.g., [19]) but were not employed here.  
 
 The possibility that molecular exchange occurs with molecules arising from the 
cell interiors is considered to be highly unlikely for HA, full-length DC-SIGN and Δ35-
DCSIGN in microdomains because this process would most likely require internalization 
of whole domains and subsequent recycling. First, recycling is expected to occur on a 
much longer time-scale than that for which FRAP measurements were carried out [20]. 
More importantly, selected domains were tracked subsequent to photobleaching and 
disappearance (internalization) of whole domains was not observed. For PMT-mRFP, it 
is possible but highly unlikely that post-bleach recovery occurred through exchange with 
unbleached molecules in the cell interior because recovery was measured over less than 
ten seconds; in any event, this effect would be expected to be small over such durations. 
Therefore, the values of P∞ and τ1/2 are interpreted as arising from the molecular mobilities 
within and outside of domains, the distance between domains, and the kinetic barriers 
associated with entry into and exit from domains. 
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Line-Scan Fluorescence Correlation Spectroscopy (line-scan FCS) 
 Measurements were carried out on live MX-DCSIGN, Δ35-MX-DCSIGN, and 
HAb2 cells, prepared as described above for FRAP measurements. Confocal microscopy 
was performed on the FV1000 instrument using the same lasers and filters as described 
above for the FRAP measurements. For each line scan, 256×1 pixels were probed at 20.0 
µs/pixel. The corresponding line time was 5.12 ms and the lag time between scans was 
1.12 ms. A total of 32,000 lines was acquired per domain. The electronic zoom of the 
microscope was 16.3, which corresponds to a line length of 12.8 µm. For all line-scans, 
the pixel size was 50 nm in length and the 1/e2-radius of the point spread function (PSF) 
was ω = 0.30 µm.  
 
 The line-scan data were analyzed using the SimFCS program (Laboratory for 
Fluorescence Dynamics, Irvine, CA). The intensity data are presented using a carpet 
representation in which the abscissa corresponds to the point along the line (pixels) and 
the ordinate corresponds to the time, with the first scan appearing at the top of the carpet 
and the last scan at the bottom. Domains were tracked and aligned to remove movement 
of the entire domain from the calculation of the molecular diffusion coefficient. A 
moving average correction was employed to remove slowly varying parameters from the 
analysis (e.g., photobleaching). Fluorescence fluctuation autocorrelation functions were 
calculated from the time-dependent, corrected data contained in each column of the 
carpet. These functions were curve-fit to G(τ) = G(0)/[1 + τ/τD ] with G(0) and τD as free 
parameters. Apparent molecular diffusion coefficients were calculated as D = ω2/4τD. 
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 The range of diffusion coefficients measurable by the version of line-scan FCS 
used in this work can be defined given the average time between line-scans (Δt = 6.24 
ms) and the total number of line-scans (32,000). Assuming that the half-time for 
autocorrelation function decay must be at least five-fold higher than the time between 
sampling individual pixels, then τD = ω2/(4D) ≥ 5 Δt. Thus, D ≤ ω2/(20 Δt) = 0.7 µm2/s. 
This upper limit is consistent with the values of D measured for HA. For the lower limit 
of measurable diffusion coefficients, if we assume that the half-time for autocorrelation 
function decay cannot be greater than the product of the scan time and one-half of the 
number of scans, then τD ≤ 16,000 Δt and D ≥ 2 x 10-4 µm2/s. This lower limit is 
consistent with (some of) the values of D measured for DC-SIGN and Δ35-DC-SIGN. 
Physically speaking, the upper limit of this range derives from the fact, that owing to 
rapid diffusion, concentration fluctuations above the upper limit of D will decay almost 
completely during the sampling interval while the lower limit originates from the need 
for some decay of a fluctuation to occur within the sampling interval. It should be noted 
that the upper limit of D can be increased by several orders of magnitude by using the 
confocal microscope, but employing raster-scan image correlation spectroscopy [21-23]. 
 
 For all measurements, G(0) values ranged from ≈ 0.0073 to 0.066. At this 
juncture, we do not feel comfortable analyzing G(0) values due to a number of 
experimental variables and insufficient theory to properly interpret the result. Primarily, 
photobleaching during data acquisition reduces the average number of fluorescent 
molecules in the probed region. Other concerns include whole cell or domain movement, 
particularly in the vertical direction which is not accounted for by the horizontal 
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alignment correction; uncertainty arising from the distribution of labels on the antibodies, 
possible self-quenching, and an unknown degree to which the molecules of interest are 
saturated with antibodies; and the lack of a theory that addresses spot-based FCS carried 
out on domains with an apparent size on the order of the spot size. These concerns may 
also raise the lower limit of intradomain diffusion coefficients measureable by line-scan 
FCS. 
 
Quantum Dot (Qdot) Single Particle Tracking 
 Qdots emitting at 610 nm (CdSe/ZnS based, Evident Technologies, Troy, NY) 
with exactly one streptavidin per Qdot were generated according to a previously 
published procedure [24]. Briefly, hydrophobic Qdots were transferred into aqueous 
solution by coating them with an amphiphilic polymer, leading to a carboxyl-terminated 
surface [25]. Next polyethylene glycol (PEG) with a terminal biotin on the free-end of the 
PEG was covalently attached to the Qdots, leading to a hydrodynamic diameter of 
approximately 15 nm [26]. These biotin-Qdots were further treated with a saturating 
concentration of streptavidin. Electrophoresis was used to isolate Qdots containing only 
one streptavidin molecule [25].  
 
 These Qdots were diluted to a working concentration of 0.1 µM with Qdot 
Incubation Buffer (Quantum Dot Corp, Hayward, CA), and used at a 0.01 µM 
concentration when pre-incubated with a large excess of biotinylated anti-human DC-
SIGN (eB-h209) or biotinylated anti-human HA (HA-7) antibodies in HHS (GIBCO 
HAMS F12 media supplemented with 15 % FBS and 25 µM HEPES) media for 1 hr, 
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rotating at room temperature. Unbound antibodies were removed by purification with a 
spin filter (Nanosep 100K Omega, PALL, Ann Arbor, MI). These complexes were then 
used to directly label live MX-DCSIGN or HAb2 cells at a concentration of 50 pM in 
HHS media, for 10 min at 25°C. Cells were then washed three times with HHS media.  
 
 Imaging was carried out on the Olympus IX81 instrument described above for co-
localization measurements (Alexa568 channel), with the addition of a 0.6 neutral density 
filter for low-light movie acquisition. Sequential images were obtained with a cooled, 
intensified Stanford Photonics (Palo Alto, CA) XR/Mega-10Z ICCD camera at 100 Hz 
using the Piper Control Imaging software package (v.2.4.40) for 10 s (1000 frames). Data 
were acquired using the Track Objects function with the Threshold Result algorithm (50 
% size match criterion). The spot of interest was defined manually by a 6×6 pixel region 
in the first frame and tracked automatically thereafter with a 10×10 pixel search area. 
Positions were determined as the centroids of the best-fits of the intensities to 2D-
Gaussians. The algorithm can accommodate up to two blank frames that may arise from 
blinking. A very small proportion (< 5 %) of trajectories were not included in the analysis 
due to excessive blinking. Traces from Qdots adhered to the glass, in areas that did not 
contain a cell, were used to determine the amount of jitter that is expected from noise 
inherent to the acquisition and analysis according to the procedure outlined in [27]. 
 
 Traces were analyzed using Microsoft Excel to calculate mean squared 
displacements (MSDs) as a function of time τ. The slopes of the first ten points of these 
 
 
76 
plots were used to calculate apparent diffusion coefficients according to MSD = 4Dτ. The 
intercepts are non-zero as previously described [27]. 
 
4.4 RESULTS & DISCUSSION 
 
4.4.1 DC-SIGN Partially Co-Localizes with Other Transmembrane 
C-Type Lectins and Clathrin. 
 Previous work has shown that DC-SIGN appears as small (several hundred nm but 
in many cases greater than optical resolution) clusters, or microdomains, on the plasma 
membranes of live and fixed dendritic cells [8-11]. While it is clear that DC-SIGN 
ectopically expressed in fibroblasts and other cell types is sufficient for microdomain 
formation [11], we asked whether other C-type lectins mix with DC-SIGN in 
microdomains on dendritic cells.  
 
 Co-localization studies, using widefield fluorescence microscopy, were carried out 
on fixed, immature human dendritic cells for two candidate molecules, dectin-1 and 
macrophage mannose receptor (MMR), which are both C-type lectin transmembrane 
proteins that might be expected to be contained in DC-SIGN domains. As shown in Fig. 
4.1, A and B, both dectin-1 and MMR are also present in microdomains. These clusters 
sometimes, but not always, co-localize with DC-SIGN microdomains (Quantified in 
Supplemental Fig. 4.1). Thus, DC-SIGN microdomains appear heterogeneous in the 
sense that they may or may not contain dectin-1 and/or MMR. Conversely, dectin-1 and 
MMR microdomains may or may not contain DC-SIGN. A variety of C-type lectin 
microdomains having different compositions could facilitate pathogen recognition, 
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internalization and subsequent antigen presentation in part by multiplexing signals from 
different pattern recognition receptors within the same domain.  
 
 Clathrin-coated pits are thought to mediate the internalization of cargo-loaded DC-
SIGN microdomains [28]. As shown in Fig. 4.1 C, individual clathrin microdomains can 
be visualized on the cell periphery. Examining the images of these regions indicates that 
clathrin microdomains are sometimes, but far from always, co-localized with DC-SIGN 
domains. This result implies that clathrin is not required for DC-SIGN domain stability. 
However, it is possible that the DC-SIGN domains containing clathrin are more mature 
and that DC-SIGN acquires clathrin prior to internalization. 
 
 The images in Fig. 4.1 were obtained from fixed (and subsequently permeabilized, 
for clathrin) cells by using two-color indirect immunofluorescence labeling. The 
observed co-localization is above what would be expected due to random distribution of 
the proteins, as determined by a bi-variate Ripley’s K-analysis (Supplemental Fig. 4.1). 
Minimal fluorescence was observed in either the green (dectin-1, MMR or DC-SIGN, in 
the case of clathrin labeling) or red (co-localized partner) channels when cells were 
treated only with the secondary, labeled antibodies and not the primary antibodies, or 
when NIH 3T3 cells (that do not endogenously express either HA or DC-SIGN) were 
stained with primary and secondary antibody, indicating specificity of labeling. It is 
highly unlikely that the domains shown in Fig. 4.1 were induced by the double-antibody 
labeling because, first, the cells were fixed prior to antibody treatment and, second, DC-
SIGN domains with very similar appearance were observed on live cells treated only with 
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fluorescently labeled anti-DC-SIGN Fabs [11]. Also, other transmembrane proteins that 
form microdomains, including some members of the tetraspanin family, do not co-
localize with DC-SIGN (data not shown). 
 
4.4.2 Comparison of DC-SIGN Microdomains with Those of HA. 
 The manner in which cells pre-form molecular subassemblies to carry out 
different functions is a topic of current interest. Thus, it is valuable to compare the 
properties of DC-SIGN microdomains with those of another membrane protein known to 
form plasma membrane microdomains. For this purpose, influenza hemagglutinin (HA) 
was selected. HA is a glycoprotein found on the surface of influenza viruses and plays a 
key role in the process through which immunological cells bind and internalize the virus, 
and subsequently present it to other immunological cells for anti-viral immunity [29]. HA 
also assembles in microdomains on virally infected cell surfaces and these HA-containing 
clusters are presumed sites of viral budding [30, 31]. When HA is expressed alone in 
uninfected cells (e.g., fibroblasts), it forms plasma membrane microdomains on both 
fixed and live cells [32, 33]. The size and density of microdomains containing HA in 
uninfected NIH 3T3 fibroblasts stably expressing HA (HAb2 cells) are roughly similar to 
those of DC-SIGN microdomains (Fig. 4.2) and are used for comparison purposes 
throughout the remainder of the work described herein.  
 
4.4.3 DC-SIGN Does Not Require its Cytoplasmic Tail to Form 
 Membrane Microdomains. 
 
 The possibility arises that the formation of DC-SIGN clusters and/or their 
subsequent stability requires molecular interactions involving the 40 amino acid N-
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terminal cytoplasmic region (Fig. 4.3 A). To address this question, mutants of DC-SIGN 
(Δ35-DCSIGN and Δ20-DCSIGN) in which the cytoplasmic domain was partially (Δ20) 
or almost completely (Δ35) deleted were ectopically expressed in NIH 3T3 cells using a 
retroviral expression system. Δ35- and Δ20-DCSIGN expression on these cell lines was 
visualized by using indirect immunofluorescence, after fixation, with the primary 
monoclonal antibody DCN46. As shown in Fig. 4.3, B and C, ectopically expressed Δ20-
DCSIGN or Δ35-DCSIGN both form membrane microdomains on NIH 3T3 cells. 
Therefore, DC-SIGN microdomain assembly and stability do not require the cytoplasmic 
tail. This result indicates either that the cytoskeleton is not required or that cytoskeletal 
factors participate in forming and maintaining DC-SIGN microdomains only through one 
or more intermediary molecules of unknown origin at present. 
 
4.4.4 Ability of Molecules within Microdomains to Exchange with 
Molecules of the Same Type from Other Cellular Regions. 
 One way to address the stability of plasma membrane microdomains is to 
characterize the degree to which molecules within the microdomains can exchange with 
molecules of the same type residing in 1) the areas of the membrane surrounding the 
domains; 2) nearby microdomains, with an intermediate step requiring diffusion through 
the distance between domains; or 3) the cell interior. Confocal FRAP was used to address 
this question. These measurements were carried out for HA, full-length DC-SIGN, Δ35-
DCSIGN, and a lipid-linked fluorescent protein residing in the inner leaflet of the plasma 
membrane (denoted as PMT-mRFP). For all four molecules, exchange mobility was 
probed for molecules residing within either HA or DC-SIGN domains. Confocal FRAP 
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was also used to examine the exchange capability of PMT-mRFP and HA in regions not 
identified as domains. 
  
 In the confocal FRAP measurements, first, small, circular regions surrounding 
single domains were selected. The mean fluorescence intensity from these circular ROIs 
was monitored before and after photobleaching. The degree of photobleaching in the 
circular tornado scan was restricted to ≈ 50 % so that the domains could be tracked as 
they moved (slightly) as a whole in the membrane following the bleach pulse. Two 
aspects related to domain stability can be addressed by this type of measurement: the 
recoverable percentage P∞ and the half-time for recovery τ1/2 (see Materials & Methods). 
The apparent diffusion coefficient can then be calculated for each τ1/2 value for the area of 
the bleach spot used in each experiment. 
 
 Fig. 4.4 A illustrates the results of a typical confocal FRAP measurement of an HA 
microdomain, labeled with Alexa488-conjugated FC125, on the surface of an HAb2 cell. 
Consistent with previous reports [34-36], overall, these measurements indicated that HA 
in microdomains exhibits a large recoverable percentage (P∞ = 68 ± 10 %, mean ± 
standard errors of the means (SEM), Table 4.1). This result indicates that HA molecules 
within their microdomains exchange with those from outside the microdomains on a 
relatively fast time-scale. The recovery times, τ1/2, in general, should depend on the sizes 
of the bleached areas, the fractions of the areas occupied by the domains, the diffusion 
coefficients of the HA within and outside of the domains, and the rates of exchange 
associated with HA moving into and out of domains. Apparent diffusion coefficients, 
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calculated for each recovery curve using the τ1/2 and the radius of the bleach spot, yielded 
an average of D = 0.10 ± 0.01 µm2/s. These values are based on the assumption that 
possible kinetic barriers for HA leaving and entering domains are negligible and that the 
D values for HA in domains and the surround are comparable. The fact that the diffusion 
coefficients are similar to those previously reported in works not emphasizing domains 
[34-36] suggests that the assumptions above are valid. 
 
 A representative confocal FRAP measurement for a domain containing full-length, 
wild-type DC-SIGN, labeled with Alexa488-conjugated DC6, on the surface of an NIH 
3T3 cell is illustrated in Fig. 4.4 B. As shown, very little to zero recovery is detectable 
after > 4 minutes. This result is consistent with previous measurements [11] and contrasts 
starkly with the results for HA domains. There are several possible explanations for the 
lack of DC-SIGN recovery: 1) DC-SIGN is extremely restricted in terms of its mobility 
within microdomains and therefore does not exchange with DC-SIGN in the surrounding 
membrane on a measurable time-scale; 2) DC-SIGN is mobile within domains, but the 
domains maintain, through an unknown molecular mechanism, a strict separation 
between molecules within the domain and the surrounding membrane; 3) the density of 
DC-SIGN between microdomains is so low and the domains are so sparse that mobility 
between domains cannot be observed by confocal FRAP. As shown below, the apparent 
diffusion coefficient of DC-SIGN within domains is extremely low and therefore the first 
explanation is the most likely one. 
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 The question arises of whether the cytoplasmic region of DC-SIGN participates in, 
or is responsible for, the dramatic, observed difference between the exchanges of HA and 
full-length DC-SIGN in microdomains with the membrane surround. Fig. 4.4 C shows a 
typical confocal FRAP measurement for a domain containing Δ35-DCSIGN, labeled with 
Alexa488-conjugated DC6, on the surface of an NIH 3T3 cell. As shown, DC-SIGN 
lacking its cytoplasmic region exhibits no appreciable difference from full-length DC-
SIGN in these measurements. The average recoverable percentage is essentially zero on 
the time scale of the measurement. Therefore, direct association of the cytoplasmic region 
of full-length DC-SIGN with the cytoskeleton can be eliminated as the primary cause of 
DC-SIGN microdomain stability. 
 
 The observation that DC-SIGN domains are heterogeneous, at least in some cases 
containing dectin-1 and MMR, raises the essential question of possible sub-domain 
structure. One issue related to this question is whether or not lipids within DC-SIGN 
domains can freely exchange with the membrane surround. Interestingly, Pinaud et al. 
[37] find that a GPI-anchored probe dynamically partitions into GM1-enriched domains 
indicating that this probe can diffuse through such domains, usually, but not always, with 
a reduced diffusion coefficient within the domain. Confocal FRAP was carried out on 
NIH 3T3 cells transiently expressing DC-SIGN and PMT-mRFP, fluorescent in the red 
channel. In these measurements, plasma membrane microdomain regions for 
photobleaching (and pre-bleach and post-bleach observation) of PMT-mRFP were 
selected by DC-SIGN expression as reflected by labeling with DCN46 followed by 
Alexa488-conjugated goat polyclonal IgG specific for mouse IgG. Microdomains were 
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identified by the green channel (DC-SIGN) fluorescence but FRAP measurements were 
carried out on these regions in the red channel (PMT-mRFP). As shown in Fig. 4.5 A and 
Table 4.1, PMT-mRFP exhibited significant recovery after photobleaching (P∞ = 69 ± 3 
%), with an apparent diffusion coefficient of D = 1.7 ± 0.2 µm2/s. These results indicate, 
first, that although DC-SIGN is extremely restrained within its plasma membrane 
microdomains, lipids are not. The percentage recoveries are equivalent to those observed 
in FRAP measurements of PMT-mRFP in regions of the plasma membrane that do not 
contain DC-SIGN (P∞ = 76 ± 6 %, D = 1.8 ± 0.2 µm2/s, Fig. 4.5, B and C, Table 4.1). 
Values of the apparent diffusion coefficients for PMT-mRFP, but not the recoverable 
percentages, are possibly underestimated because appreciable diffusion through the 
bleached region may occur during the bleach pulse. However, because the measured 
apparent D values are quite high and consistent with other measurements of PMT-mRFP 
[14] and other lipid [38] diffusion it is unlikely that these possible artifacts are significant 
within the context of the work described here. More importantly, the substantial recovery 
of the lipid analog suggests that it may diffuse between smaller, elemental units 
containing DC-SIGN, not resolvable by wide field microscopic methods. Whether the 
lipid analog can actually enter these putative units is an open question at this juncture. 
 
4.4.5 Intradomain Mobility Monitored by Line-Scan FCS. 
 As described above, confocal FRAP indicates that the rate of exchange of both 
DC-SIGN and Δ35-DCSIGN between microdomains and the surrounding membrane is 
extremely low (i.e., not observable). A possible explanation for this result is that DC-
SIGN is essentially immobile in domains (see above). To address this possibility, a 
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technique with greater spatial resolution than conventional FRAP is required. Recently, 
the inherent temporal and spatial components of data acquired with a standard laser 
scanning confocal microscope have been combined with fluorescence correlation 
spectroscopy analysis to determine rates of apparent diffusion or binding kinetics on the 
spatial scale of a single pixel [21-23]. Line-scan FCS is one such method. In this method, 
data are acquired by repetitively scanning the same single line. The data can be visualized 
by placing successive lines directly underneath the previous line-scan, creating a line-
scan carpet, which is similar to a kymograph. Temporal fluctuations in the intensity of a 
single pixel in a carpet column, sampled on the ms time scale, are sufficient to produce 
autocorrelation functions that capture aspects of membrane diffusion over an area 
determined by the point spread function (PSF) but with a spatial resolution determined by 
the lateral pixel size. 
 
 To establish the use of line-scan FCS to study the lateral diffusion of molecules 
within membrane microdomains, we initially investigated the intradomain diffusion of 
HA. HAb2 cells, stably expressing HA, were stained with anti-HA FC125 conjugated to 
Alexa488. Line-scans were acquired and arranged into line-scan carpets (Fig. 4.6 A), in 
which domains of high fluorescence intensity are color coded to appear more red on the 
carpet and background and areas of lower fluorescence intensity are color coded to 
appear more blue. The domains were centered to remove horizontal positional jitter and 
then de-trended to remove the influence of slowly varying components like 
photobleaching (Fig. 4.6 B). Apparent diffusion coefficients were calculated for single 
pixels by analyzing the fluorescence intensity fluctuations over time in single columns of 
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the line-scan carpets; these analyses were carried out for each lateral pixel in each carpet 
to determine the apparent diffusion coefficients of HA within, at the edges, and outside of 
microdomains (Fig. 4.6 C). This analysis indicated that HA is highly mobile within 
domains with a mean apparent diffusion coefficient of D = 0.127 ± 0.005 µm2/s and that 
the apparent diffusion coefficients were approximately constant across the microdomains 
(Fig. 4.6 D). The apparent D for HA outside of domains was similar (data not shown).  
 
 Line-scan FCS was next used to probe the lateral mobility of DC-SIGN and Δ35-
DCSIGN (labeled with Alexa488-conjugated DC6) within microdomains on NIH 3T3 
cells. These data indicated that both molecules are essentially immobilized within their 
domains (Fig. 4.6). The average apparent diffusion coefficients for DC-SIGN and Δ35-
DCSIGN in microdomains were found to be D = 0.0025 ± 0.0004 µm2/s and D = 0.002 ± 
0.001 µm2/s (Fig. 4.6, Table 4.1). Furthermore, for both DC-SIGN and Δ35-DCSIGN, the 
diffusion coefficient was sometimes so small that the autocorrelation functions could not 
be fit to the appropriate functional form (see Materials & Methods). These diffusion 
coefficients are in the range of the lower limit of what could be measured with line-scan 
FCS under our experimental conditions (see Materials & Methods). Thus, the results 
indicate that DC-SIGN within its microdomains, unlike HA, undergoes very little lateral 
diffusion and is immobilized in some way. This immobilization can account for the lack 
of exchange of DC-SIGN and Δ35-DCSIGN between microdomains and the surrounding 
membrane on the time scale of confocal FRAP measurements. 
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4.4.6 Defined valency Qdot tracking confirms that DC-SIGN and 
Δ35-DC-SIGN exhibit much more restricted mobility than HA within domains. 
 To corroborate the line-scan FCS results and obtain additional information, Qdot 
tracking was employed to more directly investigate the dynamics of DC-SIGN molecules 
within microdomains at high speeds and with very high spatial resolution. In this type of 
measurement, it is important to use Qdots with limited valency, as Qdots with high 
valency have the potential to cross-link DC-SIGN and yield results in which the 
measured lateral mobility is artifactually decreased. Therefore, a new synthetic Qdot 
method was employed in which Qdots covalently linked to streptavidin through 
biotinylated PEG spacers are subjected to gel electrophoresis [24]. This technique 
separates Qdots bound to none, one, or two streptavidin molecules into distinct bands, 
which are then cut from gels to isolate Qdots of defined valency [25]. 
 
 Qdots conjugated to single streptavidin molecules were preincubated with biotin-
anti-DC-SIGN or biotin-anti-HA antibodies. The maximum biotin valency of the Qdots is 
three; however, one of these biotin binding sites is most likely sterically inaccessible due 
to the streptavidin structure, strongly suggesting that the maximum valency of these 
Qdots is two. In addition, the two remaining binding sites are likely too close together to 
accommodate two antibodies. NIH 3T3 cells stably expressing HA, DC-SIGN or Δ35-
DC-SIGN were labeled with these preincubated Qdots and movies were acquired at 100 
Hz for 10 s. Single particle tracking analysis was then carried out. Tracking analysis was 
restricted to single Qdots, which were identified by avoiding very bright clusters and 
observing Qdot blinking during the video.  
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 Representative Qdot traces are shown in Fig. 4.7 and the results are summarized in 
Table 4.1. In all cases, plots of the MSD as a function of time saturated during the period 
of investigation. The initial slopes were high for HA but very low for DC-SIGN and Δ35-
DC-SIGN. Apparent diffusion coefficients were calculated from the initial slopes of these 
plots (by using only the first ten points). This analysis gave D = 0.103 ± 0.003 µm2/s (R2 
= 0.82) for HA, which is approximately equal to the value measured by FRAP and line-
scan FCS (Table 4.1). Approximately 28 % of the traces were on Qdots that were 
determined to be immobile and were not used to calculate the average D. The apparent 
diffusion coefficients for DC-SIGN and Δ35-DC-SIGN were 0.003 ± 0.001 µm2/s (R2 = 
0.76) and 0.0004 ± 0.0001 µm2/s (R2 = 0.99), respectively. Positional jitter arising from 
mechanical fluctuations, flexibility through the PEG-streptavidin-antibody linkers, and/or 
statistical noise associated with the Gaussian fits was evaluated by carrying out tracking 
analyses for Qdots strongly adhered to glass surfaces. These measurements gave apparent 
D values of 0.0025 ± 0.0001 µm2/s (R2 = 0.47). Therefore, the diffusion coefficients of 
DC-SIGN and Δ35-DC-SIGN measured by Qdot tracking are within the range of those 
produced by fluctuations due to sources other than lateral diffusion, consistent with the 
results obtained with line-scan FCS and confirming essential immobility of DC-SIGN 
within its microdomains.  
 
4.5 DISCUSSION 
 
 Pathogen recognition by DC-SIGN is implicated in the defense or infection route 
against many critical players in human disease including HIV-1, dengue virus, hepatitis 
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C, and Candida [2-4]. This calcium-dependent (C-type) transmembrane lectin is 
endogenously expressed in small microdomains on the plasma membranes of immature 
dendritic cells, key mediators between the innate and the adaptive arms of the immune 
system, and DC-SIGN clusters are required for efficient pathogen binding and 
internalization [8-11]. The manner in which DC-SIGN clusters mediate either crucial 
(infection defense) or detrimental (infection) functions is of considerable interest. In this 
work, we have reported a number of observations that both enhance current 
understanding of the structure and dynamics of DC-SIGN microdomains and also raise a 
number of intriguing questions. 
 
 Co-localization imaging showed that DC-SIGN clusters sometimes, but do not 
always, contain two other C-type transmembrane lectins (dectin-1 and MMR); 
furthermore, DC-SIGN clusters are partially co-localized with clathrin. The observation 
that DC-SIGN microdomains may or may not contain more than one C-type lectin 
implies that these clusters are heterogeneous in composition; i.e., that a spectrum of 
microdomain sub-types exists. This conclusion is supported by recent work showing that 
the multiplexing of C-type lectins is regulated so that pattern recognition receptors 
sample the phagosome in a sequential manner [39]. Multiple C-type lectins are also found 
in contact sites between dendritic cells and yeast that stimulate formation of a recently 
defined cellular protrusive structure, the fungipod, which participates in fungal 
recognition by dendritic cells [40]. The compositional heterogeneity of C-type lectin 
microdomains may be required for efficient pathogen recognition and processing.  
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 Cell imaging showed that two forms of DC-SIGN with partially or almost 
completely deleted cytoplasmic regions form plasma membrane microdomains that 
appear, within classical, light microscopic resolution, to be similar in size and distribution 
to those formed by wild-type, full-length DC-SIGN. Therefore, DC-SIGN domain 
formation and stability do not require direct interactions between DC-SIGN and 
cytoskeletal components close to the inner leaflet of the plasma membrane. However, 
whether the truncation mutants form a domain substructure identical to that of wild-type 
DC-SIGN domains remains an open question. 
 
 Consistent with previous results [11, 34-36], confocal FRAP measurements 
showed that neither DC-SIGN nor cytoplasmically truncated DC-SIGN in microdomains 
undergo measureable exchange with the pool of like proteins in the surrounding 
membrane whereas HA in microdomains [35] does exchange with the surround. Apparent 
plasma membrane diffusion coefficients calculated for HA are consistent with long range 
diffusion coefficients of a number of transmembrane proteins (≈ 0.1 µm2/s), but for DC-
SIGN and its variants, the measurements yield apparent diffusion coefficients so low that 
it is not possible to distinguish between the possibilities of extremely slow mobility and 
instrumental constraints. 
 
 To further illuminate the FRAP results, both line-scan FCS and Qdot tracking 
measurements were carried out for DC-SIGN, cytoplasmically truncated DC-SIGN, and 
HA. These measurements yielded apparent diffusion coefficients for HA, both within and 
outside of microdomains, that were consistent with the D values measured by confocal 
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FRAP. More importantly, these measurements showed that the two forms of DC-SIGN 
were so limited in their intra-domain mobilities that, again, it was not possible to 
distinguish between the possibilities of extremely slow mobility and instrumental 
limitations. Thus, the mobility of DC-SIGN variants within microdomains is very low, 
and most likely accounts for the lack of exchange between the domains and their 
surrounds observed by confocal FRAP.  
 
 Surprisingly, although DC-SIGN and cytoplasmically truncated DC-SIGN are 
unable to exchange with the membrane surround, a lipid-linked fluorescent protein bound 
to the inner leaflet of the plasma membrane does undergo significant exchange with like 
proteins in the surrounding membrane. Thus, lipid molecules can permeate and diffuse 
through these domains relatively unimpeded, suggesting that the bilayer is contiguous 
within the domains in spite of the fact that, in wide-field microscopy, they appear 
continuous and can be sized [11]. This result strongly suggests that DC-SIGN 
microdomains are not only heterogeneous in composition but also that they possess a 
complex internal structure with features smaller than can be resolved by conventional 
fluorescence microscopy, consistent with earlier results obtained with near-field 
microscopy [10]. We are currently conducting super-resolution microscopy studies to 
explore C-type lectin domain structure on smaller length scales (M.S. Itano et al., 
unpublished observations). 
 
 Precisely which protein, or perhaps lipid, components maintain the surprising 
stability of DC-SIGN in microdomains, and possibly other cell-surface microdomains 
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containing C-type lectins, is a key structural issue. DC-SIGN microdomains might be 
organized through direct interactions between DC-SIGN molecules, although this 
possibility seems at present to be too simple of a picture given that we now know that 
DC-SIGN microdomains contain a number of other molecules and have preliminary 
results from super-resolution microscopy (data not shown) suggesting otherwise. Three 
possible hypotheses for explaining the stability of DC-SIGN microdomains include 
attachments to other microdomain-forming transmembrane proteins (e.g., tetraspanins 
[41]); interaction of DC-SIGN with as yet unidentified molecules that bridge the gap to 
the cytoskeleton; and binding to members of the secreted family of galectins [42] known 
to organize membrane scaffolds. The resolution of this important issue awaits advanced 
compositional investigations. 
 
 Taken together, our results highlight the fact that DC-SIGN microdomains are 
considerably more complex than previously thought and may provide a prototype for 
certain other cell-surface, protein-containing microdomains. Moreover, signaling is 
initiated from these domains [2-4, 40] and they can be rapidly transported rearward in 
dendritic cells to sites of internalization [11]. It is clear that a better understanding of how 
the composition, structure and dynamics of C-type lectin domains mediate pathogen 
internalization could suggest means to modulate pathogen entry and antigen acquisition 
in cells of the innate immune system. 
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4.7 FIGURE LEGENDS 
 
Figure 4.1. DC-SIGN partially co-localizes with other lectins and clathrin on 
immature dendritic cells. (A,B) DIC image of a dendritic cell on left and an overlay of 
the same area stained for DC-SIGN (DCN46 and anti-mouse-Alexa568) in red and either 
Dectin-1 stained with AF1859 and anti-goat-Alexa488 (A) or CD206 stained with 
AF2534 and anti-goat-Alexa488 (B) in green on the right. (C) Overlay of a dendritic cell 
stained for DC-SIGN (H-200 and anti-rabbit-Alexa488) in green and Clathrin LC 
(CON.1 and anti-mouse-Alexa568) in red. Areas of co-localization are seen as yellow. 
Scale bars, 10 µm (A,B), 5 µm in (C).  
 
Figure 4.2. Comparison of DC-SIGN and HA microdomains. (A) DC-SIGN 
expression on a dendritic cell stained with DCN46 and anti-mouse-Alexa488. (B) HA 
expression on an HAb2 cell stained with FC125 and anti-mouse-Alexa488. Marked areas 
are shown at higher magnification in insets. Scale bars, 10 µm; Scale bar insets, 1 µm. 
 
Figure 4.3. Ectopic expression of DC-SIGN with truncations in the cytoplasmic tail 
form membrane microdomains. (A) Schematic representations, not to scale, of wildtype 
(wt) full-length DC-SIGN, ∆20-DCSIGN and ∆35-DCSIGN, the latter two of which have 
deletions in the cytoplasmic tail of DC-SIGN. The cytoplasmic tail is depicted on the left 
of the transmembrane (TM) domain, while the extracellular portion of the wt protein is 
depicted to the right of the TM domain. Two internalization motifs are present in the 
cytoplasmic tail, a di-leucine based motif (LLEEE) and a tyrosine-based motif (YKSL). 
The extracellular portion of the protein contains 7.5 tandem repeats, which are thought to 
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mediate the tetramerization of DC-SIGN, followed by a carbohydrate recognition domain 
(CRD). (DC-SIGN is a type 2 membrane protein so that its C-terminus is at the end of the 
ectodomain.) (B-D) NIH 3T3 cells stably expressing either wildtype (wt) full-length DC-
SIGN in (B), ∆20-DCSIGN in (C) or ∆35-DCSIGN in (D) stained for DC-SIGN (DCN46 
and anti-mouse-Alexa488). Marked areas are shown at higher magnification in inset. 
Scale bars, 10 µm; Scale bar insets, 1 µm. 
 
Figure 4.4. Ability of molecules within microdomains to exchange with molecules of 
the same type from other cellular regions. (A-C) Fluorescence recovery of a bleached 
domain on an HAb2 (A), MX-DCSIGN (B), or ∆35-MX-DCSIGN (C) cell stained with 
either FC125 (A) or DC6 (B,C) conjugated to Alexa488. A montage showing the 
bleaching of a representative cluster is above each recovery profile. The area of 
photobleaching is indicated by the circle in the first image. Images prior to 
photobleaching (t ≈ -10 and -5 s) are shown on the left of the small arrow, which 
indicates the first image directly following the time of photobleaching (t ≈ 0 s); images 
following photobleaching are shown to the right of the arrow (t ≈ 100 and 200 s). The 
bleached domain is indicated with a large arrow. Given the definition of P(t), the plotted 
function is zero immediately after photobleaching. Scale bars, 500 nm.  
 
Figure 4.5. Ability of lipids within DC-SIGN microdomains to exchange with lipids 
in the surrounding membrane. Representative fluorescence recovery of a bleached 
PMT-mRFP membrane region containing a DC-SIGN domain (A) or not containing a 
DC-SIGN domain (B), on an NIH 3T3 cell coexpressing PMT-mRFP and DC-SIGN. To 
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identify membrane regions containing domains, cells were stained with DC-SIGN using 
DCN46 and goat anti-mouse-Alexa488 secondary antibody. A montage showing the 
bleaching of a representative membrane region is above each recovery profile. The area 
of defined photobleaching is indicated by the yellow circle. Images prior to 
photobleaching (t ≈ -0.38 and -0.19 s) are shown on the left of the blue arrow, which 
indicates the first image directly following the time of photobleaching (t ≈ 0 s); images 
following photobleaching are shown to the right of the arrow (t ≈ 3.8 and 9.4 s). For the 
experiment in a membrane region containing a DC-SIGN domain (A), the first image in 
the montage is the same area shown in the subsequent images, but this image is for DC-
SIGN stained with DCN46 and anti-mouse-Alexa488 in green, while the subsequent 
images are for the PMT-mRFP in red. Given the definition of P(t), the plotted function is 
zero immediately after photobleaching. Scale bars, 500 nm. (C) A graph showing the 
average % recovery for PMT-mRFP on transfected NIH 3T3 cells in membrane domains 
in areas containing (left) or not containing (right) a DC-SIGN domain. Uncertainties are 
SEMs. Representative FRAP curves are from a single experiment, while the bar graph in 
Fig. 4.5 C represents an average for all of the measurements.  While the variance in data 
points for individual % recovery curves can be larger than the SEM in Fig. 4.5 C, the 
SEM refers to the variance between multiple experiments (n= 8 and 18, Table 4.1). The 
percent recoveries from the representative curves are slightly lower than the means but 
they fall within one standard deviation of the means. 
 
Figure 4.6. Intradomain mobility monitored by line-scan FCS. (A) A line-scan carpet, 
in which a single 256-pixel line is repetitively scanned (20.0 µs/pixel) on the cell 
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membrane of an HAb2 cell that has been stained with FC125 conjugated to Alexa488. 
Successive lines (~ 6 ms/line) are placed directly below the previous line. The pixel 
intensity is shown in heat map, with red indicating high intensity and blue indicating low 
intensity. There is a domain in focus centered around Column 225. (B) The line-scan 
carpet from (A) after alignment of the domain (to remove effects of movement of the 
entire domain) and removal of the effect of photobleaching (moving average subtraction). 
(C) The average apparent diffusion coefficients of columns in a domain. In this case, 
column 1 has been standardized to represent the left-most column of a domain in a given 
line-scan carpet. The average D over many domains was calculated. Line-scans were 
acquired on domains on HAb2 cells labeled with FC125 conjugated to Alexa488 (red 
line), MX-DCSIGN cells labeled with DC6 conjugated to Alexa488 (green line), or Δ35-
MX-DCSIGN cells labeled with DC6 conjugated to Alexa488 (blue line). Green and blue 
lines are essentially superimposed. (D) Apparent diffusion coefficients were calculated 
for all columns within domains and averaged from line-scans acquired as described in 
(C). Uncertainties are SEMs. 
 
Figure 4.7. Defined valency Qdot tracking confirms that DC-SIGN and Δ35-
DCSIGN exhibit much more restricted mobility than HA within domains. Qdots 
bound to a single streptavidin were pre-incubated with either biotinylated anti-HA and 
used to label HAb2 cells, biotinylated anti-DC-SIGN and used to label MX-DCSIGN 
cells, biotinylated anti-DC-SIGN and used to label Δ35-MX-DCSIGN cells, or found 
adhered to the glass in a region without a cell present. (A) Representative trajectories of 
Qdots either bound to HA (right), DC-SIGN (top left), Δ35-DCSIGN (middle left), or 
 
 
97 
adhered to the glass (bottom left) from videos acquired at 100 Hz for 10 s. (B-D) Mean 
squared displacement vs. τ plots from trajectories for Qdots bound to either HA (B), DC-
SIGN (C), or Δ35-DCSIGN (D). The best-fit line for the first 10 points from the MSD 
plots, which is used to calculate the D, is indicated by the straight black line in each plot. 
Note that the ordinate is much smaller in (C) and (D) than it is in (B). 
 
4.8  SUPPLEMENTAL FIGURE LEGEND 
 
Supplemental Figure 4.1. DC-SIGN co-localizes with other C-type lectins and 
Clathrin. (A-C) Ripley’s-K bivariate analysis is shown as L(t)-t (black line) for two 
representative analyzed images for DC-SIGN with Dectin-1 (A), CD206 (B), and Clathrin 
light chain (LC) (C). When L(t)-t is between the dashed red lines (randomness confidence 
interval), the distribution is considered random; clustering is indicated when the L(t)-t is 
above the dashed red lines. (D) Percent co-localized area of DC-SIGN with Dectin-1, 
CD206, and Clathrin-LC is shown. Error bars are SEM. 
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TABLE 4.1 
 
 
Mobility of Molecules Associated with DC-SIGN and HA Microdomains* 
 
 
 FRAP Line-scan FCS Qdot Tracking 
 P∞ D (µm2/s) n D (µm2/s) n D (µm2/s) R2 n 
HA 68 ± 10 0.10  
± 0.01 
15 0.127  
± 0.005 
 
31 0.103  
± 0.003 
0.82 25 
DC-SIGN ~ 0 ~ 0 12 0.0025 
 ± 0.0004 
 
35 0.003  
± 0.001 
0.76 31 
Δ35-DCSIGN ~ 0 ~ 0 15 0.002  
± 0.001 
 
28 0.0004  
± 0.0001 
0.99 19 
PMT-mRFP  
(non-domain) 
 
76 ± 6 1.8 ± 0.2 8      
PMT-mRFP in 
DC-SIGN domains 
 
69 ± 3 1.7 ± 0.2 18      
 
*Uncertainties are standard deviations of the means. The parameter n is the number of 
trials. 
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FIGURE 4.3 
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FIGURE 4.6 
 
 
 
 
 
105 
FIGURE 4.7 
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SUPPLEMENTAL FIGURE 4.1 
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CHAPTER 5 
Super-Resolution Imaging of C-Type Lectin and Influenza Hemagglutinin 
Nanodomains on Plasma Membranes using Blink Microscopy1 
 
5.1 SUMMARY 
 
 Dendritic cells express DC-SIGN, a C-type lectin (CTL) that binds a variety of 
pathogens and facilitates their uptake for subsequent antigen presentation. DC-SIGN forms 
remarkably stable microdomains on the plasma membrane. However, inner leaflet lipid 
markers are able to diffuse through these microdomains suggesting that, rather than being 
densely packed with DC-SIGN proteins, an elemental substructure exists. Therefore, a super-
resolution imaging technique, Blink Microscopy (Blink), was applied to further investigate 
the lateral distribution of DC-SIGN.  Blink indicates that DC-SIGN, another CTL (CD206), 
and influenza hemagglutinin (HA) are all localized in small (~80 nm in diameter) 
nanodomains. DC-SIGN and CD206 nanodomains are randomly distributed on the plasma 
                                                 
1 Reproduced/adapted with permission from: 
Itano MS, Steinhauer C, Schmied J, Forthmann C, Liu P, Neumann AK, Thompson NL, 
Tinnefeld P, Jacobson K, 2012. Super-resolution imaging of C-type lectin and influenza 
hemagglutinin nanodomains on plasma membranes using Blink Microscopy, Biophysical 
Journal, 102(7):1534-52. 
doi: 10.1016/j.bpj.2012.02.022 
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membrane whereas HA nanodomains cluster on length scales up to several microns. We 
estimate, as a lower limit, that DC-SIGN and HA nanodomains contain on average two 
tetramers or two trimers, respectively, while CD206 is often non-oligomerized. Two-color 
Blink determined that different CTLs rarely occupy the same nanodomain although they 
appear co-localized using widefield microscopy. A novel domain structure emerges in which 
elemental nanodomains, potentially capable of binding viruses, are organized in a random 
fashion; evidently, these nanodomains can be clustered into larger microdomains that act as 
receptor platforms for larger pathogens like yeasts.  
 
 
 
113 
5.2 INTRODUCTION 
 
 Immature dendritic cells are professional antigen presenting cells that mediate innate 
and adaptive immune responses by first detecting and binding to a large variety of pathogens 
[1, 2]. This antigen recognition is driven by interactions of pathogens with specialized 
receptors, highly expressed on the surface of dendritic cells, which recognize pathogen 
associated molecular patterns. C-type lectins (CTLs) are one such family of receptors, which 
recognize carbohydrate epitopes on the surface of many pathogens [3]. One CTL, DC-SIGN 
(dendritic cell-specific intercellular adhesion molecule-3-grabbing non-integrin), also called 
CD209, is a type II membrane protein that binds to a large range of clinically relevant 
pathogens, including HIV, Ebola virus, Candida albicans, and Leishmania [4]. DC-SIGN is 
expressed in microdomains on the surfaces of dendritic cells and when ectopically expressed 
in fibroblasts and other cell types [5-9]. Furthermore, in vitro studies indicate that DC-SIGN 
is most probably present as a tetramer on the plasma membrane [10-16]. Recognition of and 
binding to pathogens by DC-SIGN appears to require that the presumed DC-SIGN tetramers, 
or at least DC-SIGN as a monomer, be clustered on the plasma membrane [5].  
 
 DC-SIGN forms clusters on the cell surface even in the absence of exogenous ligands 
and these clusters enable DC-SIGN to bind to pathogens ranging in size from viruses 
(typically 80-100 nm in diameter) to yeast particles (several microns in diameter). In fact, 
previous measurements using wide-field microscopy methods have indicated that DC-SIGN 
microdomains both on human immature dendritic cells and on fibroblasts ectopically 
expressing DC-SIGN range in size from that detectable by classical optical resolution (≈300 
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nm) to ~1.5 µm in dimension [8]. Other work, using transmission electron microscopy 
(TEM) and near-field scanning optical microscopy (NSOM), has indicated that DC-SIGN 
clusters are generally less than 200 nm in diameter [5-7]. Recent results using several 
complementary fluorescence imaging-based techniques to measure the lateral dynamics of 
DC-SIGN microdomains indicated that these microdomains are remarkably stable [8, 9]. 
However, fluorescence recovery after photobleaching experiments determined that lipids can 
permeate and diffuse through DC-SIGN microdomains [9], suggesting that, rather than being 
densely packed with DC-SIGN proteins, there may be a complex internal structure to DC-
SIGN microdomains that are viewed as continuous structures using wide-field fluorescence 
microscopy. Throughout this paper, we will refer to domains observable by wide-field 
fluorescence microscopy, having a resolution limit of ~300 nm, as “microdomains”, while 
domain structures with dimension ~100 nm or less, which are only observable by super-
resolution methods, will be referred to as “nanodomains”. 
 
 The studies reported in this paper describe results obtained by using a super-
resolution imaging technique, Blink Microscopy (Blink), to examine the nanostructure of 
DC-SIGN microdomains on fixed dendritic cells. Blink Microscopy is one of several recently 
developed methods that use sequential, sparsely distributed single-molecule imaging to 
generate plots of precise locations of single molecules, with a resolution of ~30 nm [17]. This 
method employs oxidation and reduction agents to drive the majority of the dyes into 
transient dark states, with only a few sparsely-distributed dyes fluorescing, with ms-long on 
times, at a time. Blink offers several advantages for biological applications as it permits the 
use of commercial dyes (and therefore doesn’t require over-expression of a fluorescent 
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protein fusion), it utilizes fast (<60 seconds) times for image acquisition (2-4000 frames at 30 
ms integration times), and is experimentally simple to set-up (requiring only the use of 
standard immunostaining practices and the exchange of soluble buffers). However, as with 
many of the other super-resolution imaging methods, Blink is most effective when imaging 
fixed cells using total internal reflection fluorescence (TIRF) microscopy, and therefore can 
be most easily applied to image proteins at or very near the ventral cell surface or coverslip.  
 
 For comparative purposes, the distribution of DC-SIGN at sub-optical resolution was 
complemented by observations of another protein, influenza hemaggultinin (HA). HA is 
located in the viral envelope, but also forms plasma membrane microdomains when 
ectopically expressed in non-infected cells. The propensity for HA to form microdomains on 
plasma membranes is presumably related to subsequent viral budding [18, 19]. Analysis of 
Blink images determined that DC-SIGN and HA are predominantly expressed in small 
nanodomains, ~80 nm in diameter. However, while statistical analyses demonstrated that 
DC-SIGN nanodomains are randomly distributed on dendritic cell surfaces, the same 
analyses indicated that HA nanodomains are not randomly distributed on NIH 3T3 HAb2 cell 
surfaces at length scales up to and beyond 1 µm. Finally, the number of Blink localizations 
per nanodomain indicated that DC-SIGN and HA nanodomains generally contain fewer than 
12 molecules, suggesting that these nanodomains are not densely packed with DC-SIGN or 
HA molecules, respectively, leaving room for other protein and lipid components.  
 
 To determine whether the spatial arrangement of DC-SIGN is representative of other 
members of the CTL family of proteins, Blink was applied to investigate the lateral 
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distribution of another CTL family member, CD206. Analysis of Blink images indicated that, 
similar to DC-SIGN, CD206 is also generally expressed in randomly distributed, small (<80 
nm in diameter) nanodomains. However, CD206 nanodomains appear to contain fewer 
molecules on average than DC-SIGN and HA nanodomains. Further, two-color Blink 
imaging determined that different CTLs (DC-SIGN and CD206) are generally confined to 
separate nanodomains and rarely co-exist within the same nanodomain, though when viewed 
by widefield microscopy they appear to be co-localized.  
 
 Overall, the results reported here indicate that there is a lateral organization of 
nanodomains within DC-SIGN and CD206 microdomains, which cannot be resolved by 
wide-field fluorescence microscopy; give a considerable amount of quantitative insight with 
respect to this complexity; and raise key questions concerning structure-function 
relationships for certain classes of membrane receptor clusters.  
 
5.3 MATERIALS & METHODS 
 
Cells 
 Human monocyte-derived immature dendritic cells were prepared from human whole 
blood obtained from the New York Blood Center (Long Island City, NY) as previously 
described [8, 9]. Peripheral blood mononuclear cells were isolated from the blood by 
centrifuging over a Ficoll gradient (Ficoll-Paque PLUS, GE Healthcare, Uppsala, Sweden) 
and resuspended in Dulbecco’s phosphate-buffered saline (DPBS, 0.08 M sodium phosphate, 
0.14 M NaCl, pH 7.4, GIBCO, Grand Island, NY) with 0.5 % (w/v) bovine serum albumin 
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(BSA, Santa Cruz Biotechnology, Santa Cruz, CA). Monocytes were culled from the 
peripheral mononuclear cells by adherence to tissue culture flasks for 2-3 hours followed by 
washing with RPMI-1640 medium containing 10% fetal bovine serum (FBS). After 
approximately 24 hours detached cells were replated on LabTek 8-well chambered cover 
slides (cat# 177402, Nunc, Rochester, NY) with RPMI-1640, 10 % FBS, 500 U/ml of human 
IL-4 and 800 U/ml of human GM-CSF (Peprotech, Rocky Hill, NJ) to stimulate development 
of immature dendritic cells. An NIH 3T3 cell line (called HAb2) that permanently expresses 
HA from the Japan strain of influenza was obtained from Judith White (University of 
Virginia, Charlottesville, VA). These cells were maintained in culture using high glucose 
DMEM with 10 % FBS. 
 
Antibodies 
 For single-color Blink measurements, two primary antibodies were prepared in-
house. The mouse hybridoma DC6, which secretes IgG1 specific for human DC-SIGN [20], 
was a gift of Robert Doms (University of Pennsylvania, Philadelphia, PA). The mouse 
hybridoma FC125, which secretes IgG2a specific for human HA [21], was obtained from 
Thomas Braciale (University of Virginia). In both cases, hybridomas were grown in PFHM-
II protein-free hybridoma medium (GIBCO). DC6 and FC125 IgG were purified from 
hybridoma supernatants by Protein A affinity chromatography (Pierce Biotechnology, 
Rockford, IL). The column was sequentially washed with 100 mM and 10 mM Tris at pH 8.0 
and eluted with 50 mM glycine at pH 3.0. Eluates (1-4 ml) were immediately neutralized 
with 1 M Tris (pH 8.0), concentrated by using spin columns (Ultracel-10k; Millipore, 
Billerica, MA) and dialyzed with Slide-A-Lyzer cassettes (Pierce Biotechnology) against 4 L 
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PBS (diluted from PBS, 10×, Cellgro, Manassas, VA). The goat polyclonal IgG AF2534, 
which is specific for human CD206 (also known as MMR, Macrophage Mannose Receptor), 
was obtained commercially (R&D Systems, Minneapolis, MN). Commercially available goat 
anti-mouse Fab (Rockland, #810-1102, Hamburg, Germany) and rabbit anti-goat Fab 
(Rockland, #305-4102) were used as secondary antibodies. These Fabs were labeled with 
ATTO655-NHS (ATTO-TEC, Siegen, Germany) in PBS (pH 8) for 3 hours at room 
temperature. Excess dye was removed by a NAP-5 size exclusion column (GE Lifesciences, 
Munich, Germany). The degree-of-labeling was determined to be ~1 dye/protein by 
absorption spectroscopy. By using single-step photobleaching experiments, we estimated that 
fluorescently labeled Fabs contained approximately 1-2 fluorophores per protein (mean = 
1.4, max = 3, n = 46; Supporting Figure 4.2). For the two-color Blink measurements, the 
primary antibodies were the mouse monoclonal IgG DCN46, specific for human DC-SIGN 
(R&D Systems) and AF2534. The secondary antibodies were Alexa546-conjugated donkey 
anti-mouse IgG (Invitrogen, Carlsbad, CA) and ATTO655-conjugated rabbit anti-goat Fab 
(see above). 
 
Sample Preparation 
 Cells were initially plated on LabTek 8-well chamber cover slides (Nunc) in the 
appropriate medium. Cells were then fixed by using a paraformaldehyde solution [4 % (v/v) 
in PBS, pH 7.4] for 20 minutes at 25°C and then maintained in PBS/BSA overnight at 4°C. 
All subsequent steps were carried out at room temperature. On the day of Blink 
measurements using a single color, cells were treated with the appropriate primary IgG 
(DC6, AF2534 or FC125) at 10 µg/mL in PBS/BSA for 20 min, washed with PBS/BSA, 
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stained with the appropriate ATTO655-Fab as the secondary antibody at 0.5 µg/mL in 
PBS/BSA for 15 min, and then washed with PBS/BSA. On the day of two-color Blink 
measurements, cells were first treated AF2534 at 50 µg/mL in PBS/BSA for 20 min, washed 
with PBS/BSA, stained with rabbit-anti-goat ATTO655-Fab at 0.5 µg/mL in PBS/BSA for 
15 min, and then washed extensively with PBS/BSA. The cells were then treated with 
DCN46 at 10 µg/mL in PBS/BSA for 20 min, washed with PBS/BSA, stained with donkey-
anti-mouse Alexa546 IgG at 0.5 µg/mL in PBS/BSA for 15 min, and then washed with 
PBS/BSA. 
 
 For these conditions, dendritic cells were most likely saturated with primary and 
secondary antibodies. This conclusion is derived from measurements in which it was 
determined that a region of interest (ROI) imaged under constant imaging conditions with 
varied concentrations of primary and secondary antibody had reached maximum fluorescence 
intensity. The antibody concentrations were selected to be the minimum dilution that 
achieved the maximum fluorescence intensity of the ROI. 
 
Blink Microscopy 
 Fluorescence imaging was carried out on an Olympus IX-71 applying an objective-
type total internal reflection fluorescence (TIRF) configuration with an oil-immersion 
objective (PlanApo N 100×, NA 1.40, Olympus). For illumination, a high power single mode 
diode laser (λ = 650 nm, XTL, Toptica Photonics, Munich, Germany) was used, illuminating 
an area of about twice the size of the observation area (~3000 µm2). The focal length of the 
focusing lens was 100 mm. Prior to passing through the focusing lens, the Gaussian profile 
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beam was expanded to ~ 1 cm in diameter. The laser beam was passed through a clean-up 
filter (Brightline HC 650/13, AHF Analysentechnik, Tuebingen, Germany) and coupled into 
the microscope objective by a dual-band beamsplitter (z532/658 rpc, AHF Analysentechnik). 
Fluorescence was spectrally filtered with an emission filter (HQ 700/75 M, AHF 
Analysentechnik) and imaged on an EMCCD camera (Ixon DU-897, Andor Technology, 
Belfast, Northern Ireland). For two-color experiments, a second high power single mode 
diode laser (λ = 532 nm, MPB Communications, Montreal, Canada) was used and imaged by 
a second Ixon DU-892 EMCCD camera (Andor). The green laser beam was passed through a 
clean-up filter (HC Laser Clean-up MaxLine 532/2, AHF Analysentechnik) and coupled into 
the microscope objective by a dual-band beamsplitter (z532/658 rpc, AHF Analysentechnik). 
Green fluorescence was spectrally filtered with an emission filter (HQ 582/75 M, AHF 
Analysentechnik).  
 
 Cells labeled with primary and secondary antibodies were imaged in PBS containing 
both 50-100 µM ascorbic acid (AA) and 0-75 µM N,N-methylviologen (MV). AA and MV 
concentrations were adjusted to gain sufficient localizations within 20 seconds; within this 
time mechanical drift is not significant (see [22] for details of how to adjust blinking for 
super-resolution microscopy). The typical laser power used for imaging was 200 mW (5 
kW/cm2 at the specimen plane). 2000–6000 frames were recorded at frame rates of 111-250 
Hz. The laser powers were chosen to adapt the on-times of the fluorophores to the shortest 
possible integration time of about 4 ms of the EMCCD camera. Under these conditions, 
ATTO655 emits approximately 1000 photons per on-time [23]. This level of emission 
provides a S/N ratio of about 30 before background subtraction. For the two-color 
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experiments, the red and green images were acquired sequentially; first the red (ATTO655) 
image was acquired, and then the green (Alexa546) image was acquired. This method was 
implemented to reduce excitation by the green laser in the red channel. For two color images, 
the images were aligned for offset due to chromatic effects by imaging sparsely distributed 
beads fluorescent in both channels (40 nm Transfluor, Invitrogen) on glass prior to imaging 
cells on each day of image acquisition. To optimize the blinking of both fluorophores for 
two-color measurements, some cells were imaged in an alternative solution that achieved 
oxygen removal enzymatically (2% glucose in PBS with 50 µg/ml glucose oxidase, 100-200 
µg/ml catalase, 0.1 mM TCEP-HCl (Sigma)) and contained 1- 50 mM cysteamine (MEA, 
Sigma) as a reducing agent. 
 
Single-step photobleaching 
 Samples were prepared as for Blink Microscopy, except that cells were imaged in 
PBS without any other reagents added. The laser intensity was set to moderate power and 
1000-2000 frames were recorded with an integration time of 100 ms until all fluorophores 
were bleached. 
 
Image Reconstruction 
 Movies were analyzed by custom-made software written in LabView 2009 (National 
Instruments, Austin, TX) as in [22]. The first frames of movies were discarded because in the 
beginning all molecules are in the active state. The algorithm analyzes the movie frame by 
frame, and each local peak intensity within a frame is compared with its environment. When 
the peak intensity is at least 1.4 times higher than its environment, the spot is considered for 
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further analysis. This threshold automatically adapts to the background level in the 
immediate environment of the molecule under consideration. Two-dimensional Gaussian 
fitting yields the position of the molecules that are histogrammed for image reconstruction. 
To further exclude events with two molecules being simultaneously active within a 
diffraction-limited area and to remove cases when the two-dimensional Gaussian fitting does 
not converge, a circularity criterion of the identified spots has to be met. Specifically, this 
means that the ratio of the width of the Gaussian fit in the x-dimension vs. the y-dimension 
must be less than 1.2. To construct a super-resolution image from the localizations, each 
pixel of the original image was divided into 5 super-resolution pixels, resulting in a 20 nm 
pixel size in the Blink image.  
 
Localization precision 
 For Blink Microscopy images, the localization precision is mainly determined by the 
on-counts, or the number of photons (N) per on-time [24]. The localization precision is 
expected to be on the order of ~s/(N1/2) = 22 nm, where s represents the standard deviation of 
the center of the point-spread-function. This value translates to a full-width half-maximum 
(FWHM) of ~50 nm for a single molecule being localized multiple times. Experimentally, 
the localization precision was determined by imaging ATTO655-Fab secondary antibodies 
adhered to glass. Accordingly, single molecules are localized with a FWHM = 39 nm (Table 
5.1, Fig. 5.4).  
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Convolution of Blink images 
 To compare the distribution of Blink localizations with an image of the same area of 
the cell with standard TIRF illumination, the Blink image was convoluted with a diffraction-
limited point-spread function (PSF). First, ImageJ was used to define an appropriate 
diffraction-limited PSF using the ‘Diffraction PSF 3D’ plugin (OptiNav, Inc., Bellevue, WA) 
and the relevant information for the microscope used to acquire the Blink movies (described 
above). The PSF had a Rayleigh’s criterion of ~14 pixels, or ~280 nm. The image of the PSF 
and the Blink image were used with another ImageJ plugin, ‘Convolve 3D’ (OptiNav, Inc.), 
which convolves the Blink image with the PSF.  
 
Nanodomain size fitting 
 To calculate nanodomain size, first, ImageJ was used to identify domain boundaries. 
For all images, peaks were identified by binarizing the image by using the ‘Make Binary’ 
routine in the software package ImageJ. Peak positions were identified using the `Analyze 
Particles' routine, which returned a list of centroids and a new image depicting outlines for 
spots meeting the condition of area ≥ 4 pixels. Square regions of interest (ROIs) were hand-
drawn around each of the spots identified by ImageJ on the original Blink image in the 
Labview software. The distributions of the Blink localizations within the ROIs were then fit 
to two-dimensional Gaussian functions. The FWHMs were used to estimate the domain 
diameter. For “Overall FWHM” measurements, the FWHM from each dimension was treated 
as a separate measurement, so in general, there were twice as many FWHM measurements 
used in this calculation than the number of domains or ATTO655-Fab dyes analyzed. Very 
rarely (for ~1 % of the dyes), the distribution of Blink localizations for a single ATTO655-
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Fab on glass was only a single pixel wide in one dimension (x- or y-). In these instances it 
was not possible to fit to a Gaussian in that dimension, so only one FWHM measurement was 
reported instead of two. 
 
Analysis of the spatial distribution of nanodomains. 
 The distribution of nanodomains on the plasma membrane was analyzed using PAST 
[25] and CellSpan (University of New Mexico, Albuquerque, NM) software. Domain 
centroids for the analysis were input from the list given by the ImageJ ‘Analyze Particles’ 
routine (as in Nanodomain size fitting) on Blink images that were cropped to exclude cell 
boundaries and space not occupied by the cell. Both Ripley’s K - based statistics and a 
modified Hopkins function were used to compare the distributions of DC-SIGN, CD206 and 
HA Blink domains to that of a random distribution. The PAST program was used to run the 
Ripley’s K test, and details regarding this software are described in [25]. In the case of the 
Ripley’s K test, the function K(r) indicates the probability of encountering another centroid at 
the length scale denoted on the r-axis. For random distributions the function K(r) is 
proportional to the density of the centroids and πr2. Red lines in the plots represent a 95% 
confidence interval for complete spatial randomness, calculated from 1000 Monte Carlo 
simulations of randomly distributed points for each image. Clustering is indicated at length 
scales where K(r) is greater than that expected due to a random distribution of points. The 
CellSpan program was used to run the modified Hopkin’s test for spatial randomness, which 
compares the distances between random data points and nanodomain centroids to the actual 
distances between nanodomain centroids. Details of the CellSpan program and statistics used 
are described in [26]. A random distribution is indicated by a function that is shaped like a 
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normal “bell” curve centered at the Hopkin’s statistic 0.5 on the abscissa. Clustering is 
indicated if the plot is shifted to the right. 
 
 Simulations of Blink Microscopy images of two randomly distributed sets of clusters, 
in which any overlap is of a stochastic nature, were created using a custom-built Labview 
program. This program created images with clusters equivalent to the mean size measured for 
DC-SIGN and CD206 and exponential distributions of the mean number of blink 
localizations measured for each domain type. The clusters were randomly distributed with a 
density of 200 domains of each type per image with the number of blink localizations per 
domain determined by an exponential distribution with a mean equal to 200. 
 
 For percent co-localization analysis, the area of co-localization was determined by 
dividing the number of pixels that contained both red and green signal by the total number of 
pixels with red signal.  In total, 200 simulated images and 20 two-color Blink images were 
analyzed. 
 
 To determine whether the co-localization was above what would be expected for two 
randomly distributed sets of clusters, in which any overlap is of a stochastic nature, a 
Ripley’s-K bivariate analysis was applied. The final domain images were cropped to exclude 
cell boundaries and their centroids were identified using the Particle Analyzer. The centroids 
were used as input for the Cellspan software (University of New Mexico, New Mexico) to 
perform ‘Ripley’s K for bivariate data’ analysis. Output is provided in the form of the L 
function, L(t)-t, as previously described [26]. This function transforms Ripley’s K function to 
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a form where L(t)-t=0 for random distributions at all length scales (t). When L(t)-t (black 
line) is within the confidence interval for randomness (i.e., between the red lines), this 
indicates a random distribution. L(t)-t greater than the randomness confidence interval 
indicates clustering on the length scales denoted on the abscissa of the graph. 
 
5.4 RESULTS 
 
5.4.1 Blink Microscopy on DC-SIGN Plasma Membrane Nanodomains. 
 DC-SIGN forms remarkably stable microdomains on the plasma membrane that range 
in size, as estimated from wide-field fluorescence microscopy, from the diffraction limit to 
~1.5 µm in dimension [8, 9]. However, inner leaflet lipid markers are able to diffuse through 
these microdomains suggesting that rather than being densely packed with DC-SIGN 
proteins, an elemental substructure exists [9]. Therefore, a super-resolution imaging 
technique, Blink Microscopy [17], was applied to further investigate the lateral distribution 
of DC-SIGN within microdomains on the plasma membrane. Blink Microscopy achieves 
sub-diffraction-limited resolution by precisely localizing single molecules that are 
stochastically imaged in a sequential manner so that no more than one molecule is actively 
emitting fluorescence within the point-spread function (PSF) of the molecule [27].  
 
 Prior to antibody staining and imaging, all cells were fixed by using a 
paraformaldehyde solution [4 % (v/v) in PBS, pH 7.4] for 20 minutes at 25°C and then 
maintained in PBS/BSA overnight at 4°C. Fixed monocyte-derived immature dendritic cells 
were stained for DC-SIGN using indirect immunofluorescence with DC6 IgG and 
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ATTO655-Fab. Blink Microscopy images were generated from movies taken while the dyes 
were induced to blink with ms-long on-times in the presence of reducing and oxidizing 
agents. Specifically, cells labeled with primary and secondary antibodies were imaged in 
PBS containing both 50-100 µM ascorbic acid (AA) and 0-75 µM N,N-methylviologen 
(MV). AA and MV concentrations were adjusted to gain sufficient localizations within 20 
seconds.  Each point in a Blink image represents the precise location of a single molecule 
given by fitting the spatial distribution of the fluorescence from a single molecule to a 
Gaussian function. Figure 5.1 shows a representative image (one of 17 images analyzed): 
Figure 5.1 A gives the conventional TIRF image; Figure 5.1 B gives the Blink image; and 
Figure 5.1 C gives an overlay of the Blink image and the TIRF image. As can be readily seen 
by comparing Figures 5.1 A and B, Blink Microscopy provides a much higher resolution in 
terms of localizing centroids of DC-SIGN micro/nanodomains in the same region of the cell. 
For example, in some cases where a single region of fluorescence or microdomain is viewed 
using TIRF, the Blink image indicates that this area is actually comprised of several very 
small nanodomains (Fig. 5.1 C, inset). Additionally, the TIRF image (Fig. 5.1 A) and the 
corresponding computer-generated convolution of the Blink image to a corresponding wide-
field image (Supporting Fig. 5.1) are very similar. Nonetheless, these two images are not 
completely identical. Most of the variation is due to differences in relative pixel intensity 
values between the two images, because the values in Fig. 5.1 A reflect actual fluorescence 
intensities, while the values in Supporting Fig. 5.1 were generated computationally. In 
addition, the number of Blink localizations within a pixel area should be, for the most part, 
correlated with the number of fluorophores in the area, but will also depend on the specific 
blinking properties during the imaging conditions (e.g., how long given fluorophores were in 
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the on-state), possible differences in photobleaching, and the likelihood that more than one 
fluorophore within the PSF at a given location is in an on-state at the same time. 
Furthermore, there are some areas in the TIRF image (A) that do not appear in either the 
Blink image (B) or the Blink image following convolution (Supporting Fig. 5.1), most likely 
because the TIRF image is taken at the beginning of the movie (when all fluorophores are in 
the on-state) but subsequently some of the fluorophores irreversibly photobleach and are not 
able to be detected by Blink. 
 
5.4.2 Size Estimation of DC-SIGN Plasma Membrane Nanodomains 
using Blink Microscopy. 
 Blink Microscopy images of DC-SIGN on fixed dendritic cells stained with DC6 and 
anti-mouse ATTO655-Fab allowed visualization of small DC-SIGN nanodomains on the 
plasma membrane. To determine the range in sizes of these nanodomains, the Blink images 
were analyzed using ImageJ and custom-built Labview software. Nanodomains were first 
identified using the ‘Particle Analyzer’ routine in ImageJ (Fig. 5.2). The spatial distributions 
of Blink localizations in each nanodomain were then fit to two-dimensional Gaussian 
functions and the full-width half-maximum (FWHM) values of the fitted Gaussian functions 
were used to estimate nanodomain diameters (Fig. 5.2). The average FWHM for DC-SIGN 
nanodomains was 76 ± 42 nm (mean ± standard deviation (SD) for 3706 FWHM 
measurements, derived from 1853 nanodomains on 17 cells; Table 5.1 and Fig. 5.3). It is 
notable that the majority of the DC-SIGN nanodomains are smaller than 100 nm in diameter 
(Fig. 5.3), which is significantly less than the ~500 nm microdomain dimension observed in 
TIRF and epifluorescence images (Fig. 5.1 A and [8]). These results are consistent with those 
from other studies using methods with high spatial resolution, TEM and NSOM, which have 
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also determined that DC-SIGN is predominantly localized in domains less than 200 nm in 
diameter [5-7]. However, the DC-SIGN nanodomains imaged by Blink Microscopy are 
slightly smaller on average than those that were previously analyzed using these other 
techniques. For the NSOM measurements, the average DC-SIGN domain size (~100 nm) was 
at the lower limit of spatial resolution for this method (90-100 nm). Furthermore, the 
relatively large (10 nm) gold particles used for labeling antibodies for the TEM experiments 
may have resulted in slightly larger domain size measurements.  
 
5.4.3 Comparison of Size Estimation of DC-SIGN Plasma Membrane 
Nanodomains to Those of Influenza HA and CD206, Another C-Type 
Lectin, using Blink Microscopy. 
 
 While the results presented thus far have primarily focused on describing the spatial 
distribution of DC-SIGN, work focused on describing heterogeneity on the plasma 
membrane and the downstream consequences of such molecular assemblies has become an 
issue of considerable interest. Influenza hemagglutinin (HA) domains, when HA is 
ectopically expressed, have been investigated by different imaging modalities [28, 29], and, 
therefore, it is useful to compare our results from DC-SIGN to those from HA. HA is a 
glycoprotein that is expressed on the envelope of influenza viruses and is required for the 
virus to bind to and be internalized either by target cells for infection or by immunological 
cells for antiviral immunity [30]. On virally infected cells, HA assembles into plasma 
membrane domains, presumably at sites of subsequent viral budding from the cell surface 
[18, 19]. When HA is ectopically expressed in fibroblasts, without other viral proteins, HA 
appears to accumulate into domains (ranging from 30 nm to several microns in diameter) on 
the plasma membrane of fixed and live cells [18, 28, 29]. Consistent with these previous 
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findings, Blink Microscopy on fixed HAb2 cells, an NIH 3T3 cell line that stably expresses 
HA, indicates that the protein is distributed in clusters on the cell surface. The size 
distribution of these clusters was analyzed using the same method described above for DC-
SIGN. Similar to the distribution of DC-SIGN, HA is expressed in small nanodomains, the 
majority of which are less than 100 nm in diameter (Table 5.1 and Fig. 5.3). These 
nanodomains of HA were similar in dimension to the “compact clusters” described by Hess 
et al (2007); however, because our analysis did not include the cell margins, we did not 
analyze the “elongated clusters” observed earlier [28]. 
 
 Additionally it is useful to compare the clustering of DC-SIGN to that of another CTL 
family member, CD206, to investigate whether the spatial arrangement of DC-SIGN is 
representative of other members of the CTL family of proteins. Previously, it was determined 
that CD206 was also expressed in microdomains on the plasma membrane of dendritic cells, 
and that these microdomains sometimes co-localized with DC-SIGN microdomains (9). 
Blink Microscopy on fixed dendritic cells stained with AF2534 and anti-goat ATTO655-Fab 
determined that CD206 is also expressed in nanodomains, which are 70 ± 41 nm in diameter 
(Table 5.1 and Fig. 5.3). This result suggests that other CTLs may also have a distinct 
nanoscale architecture.  
 
5.4.4 Estimated Localization Precision of Blink Microscopy by Imaging Single 
ATTO655-Fab Molecules on Glass. 
 
 Similar to other super-resolution imaging techniques that use stochastic activation of 
fluorophores, each dye imaged by Blink Microscopy is typically localized multiple times (fit 
to Gaussian functions in multiple frames) in the final Blink image. Therefore, while the 
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localization precision of a single dye in a single frame depends on the number of photons 
collected [24], the localization precision of a single dye in a Blink image is also related to the 
spatial distribution of all of the Blink localizations derived from a single dye. To determine 
localization precision including the influence of multiple localizations of single dyes, Blink 
images of sparsely distributed single anti-mouse ATTO655-Fab molecules on glass were 
analyzed. Based on the number of bleaching steps for many individual ATTO655-Fabs, the 
average dye to protein ratio was determined to be 1.4 (Supporting Fig. 5.2). The average 
FWHM of the Gaussian fits to the distributions of Blink localizations from single ATTO655-
Fabs on glass was 39 ± 11 nm (191 FWHM measurements, 97 dyes; Table 5.1). It is notable 
that the average FWHM measurements for DC-SIGN and HA nanodomains are significantly 
larger than the localization precision for a single fluorescent Fab (Fig. 5.3); therefore it is 
highly unlikely that the FWHM measurements of DC-SIGN are of single Fabs, and much 
more likely that the FWHM measurements refer to the dimensions of DC-SIGN 
nanodomains on the plasma membrane. 
 
5.4.5 DC-SIGN and CD206, but Not HA, Nanodomains are Randomly Distributed 
on the Plasma Membrane. 
 
 Blink Microscopy provides high-resolution spatial distribution data, which allows 
mapping of the precise locations (or centroids) of nanodomains and makes possible 
discrimination between whether DC-SIGN and CD206 nanodomains are randomly or non-
randomly distributed on the cell surface. Using the PAST [25] and the CellSpan [26] analysis 
programs, Ripley’s K and modified Hopkin’s tests were applied to the distributions of 
nanodomain centroids from Blink images that were cropped to exclude cell boundaries and 
areas not covered by a cell, respectively. In the case of the Ripley’s K test, the PAST 
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program was used to calculate the function K(r), which indicates the probability of 
encountering another centroid at the length scale denoted on the r-axis. For random 
distributions the function K(r) is proportional to the density of the centroids and πr2. Red 
lines in the plots represent the 95% confidence interval for complete spatial randomness 
calculated from 1000 Monte Carlo simulations of randomly distributed points for each 
image. Clustering is indicated at length scales where K(r) is greater than that expected due to 
a random distribution of points. Cellspan’s modified Hopkin’s test for spatial randomness 
compares the distances between random data points and nanodomain centroids to the actual 
distances between nanodomain centroids. A random distribution is indicated by a function 
that is shaped like a normal “bell” curve centered at the Hopkin’s statistic 0.5 on the abscissa. 
Clustering is indicated if the plot is shifted to the right. For both of these analyses, the 
distribution of DC-SIGN and CD206 nanodomain centroids aligns closely with the expected 
result for a random distribution (Fig. 5.4 A-F). This finding agrees with the NSOM data [6]. 
 
 Very different results were obtained when the same analysis methods were applied to 
centroids derived from Blink images of HA (Fig. 5.4 G-I). For every HA image analyzed (12 
of 12 images), the modified Hopkin’s test indicated clustering and the Ripley’s K test 
indicated clustering of multiple nanodomains across all length scales up to 1 µm. For the 
Ripley’s K test, clustering is indicated by the K(r) statistic being greater than the value 
expected for a random distribution at the length scales indicated by the values on the 
abscissa. The K(r) statistic for HA nanodomain centroids was consistently greater than the 
parabolic curve expected for a random distribution from the shortest distances measureable 
(~30 nm) to greater than 1 µm. In many cases, the Ripley’s K test indicated clustering for 
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even longer distances. These results are consistent with previous analysis of the distribution 
of HA using electron microscopy and fluorescence photoactivation localization microscopy 
(FPALM) [28]. These results also indicate that the assembly and/or the maintenance of DC-
SIGN and CD206 nanodomain distributions on the cell surface are regulated by distinct 
mechanisms from those that occur with HA nanodomains. 
 
5.4.6 Estimated Occupancy of DC-SIGN in Single Nanodomains 
using Blink Microscopy. 
 
 Because the number of Blink localizations in a DC-SIGN nanodomain is, on the 
average, proportional to the number of molecules in the nanodomain, it is possible to 
estimate the occupancy of DC-SIGN in nanodomains using data derived from Blink images 
of DC-SIGN on fixed dendritic cells. A single molecule, in this case a single Fab, will blink 
with a characteristic rate, leading to an average number of Blink localizations that will be 
derived from a single Fab imaged with consistent experimental conditions.  The average 
number of Blink localizations from a single Fab was 25 ± 18 (97 dyes analyzed; Table 5.1, 
Fig. 5.5 A). There is variability in the number of Blink localizations from single Fabs as 
different molecules may have zero, one, two or perhaps even three conjugated fluorophores 
(Supplemental Fig. 5.2). In addition, the blinking of each dye is a stochastic process 
sometimes leading to the dye having slightly longer or shorter on-times during the imaging 
process, leading to more or fewer blink localizations per single dye in a given blink image. 
Using the same laser power, camera integration time, concentrations of antibodies and 
analysis conditions, the average number of Blink localizations from a single DC-SIGN 
nanodomain was found to be 163 ± 230 (1960 nanodomains analyzed; Table 5.1, Fig. 5.5 A). 
As shown in Fig. 5.5 A and indicated by the large standard deviation of the measurement, 
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there is a large variability in the number of Blink localizations from single DC-SIGN 
nanodomains. The total number of Blink localizations in a single nanodomain is equal to the 
sum of Blink localizations from all of the single molecules in the nanodomain. Therefore, an 
estimate of the occupancy of DC-SIGN in single nanodomains was calculated by dividing the 
number of Blink localizations in a single nanodomain by the average number of Blink 
localizations from a single dye. The majority of both DC-SIGN and HA nanodomains 
contain fewer than 12 molecules (7 ± 10 and 5 ± 6, respectively) with a few nanodomains 
(less than 100 nm in diameter) of each type accommodating upwards of ~65 molecules 
(Table 5.1, Fig. 5.5 A). CD206 nanodomains, on the other hand, appear to contain fewer 
molecules on average, with a larger population of what appear to be single, non-oligomerized 
molecules on the cell surface (Table 5.1, Fig. 5.5 A). Given the average diameter of the 
ectodomain of a tetramer of DC-SIGN of ~8 nm [31, 32], we calculated that ~360 molecules 
of DC-SIGN or ~90 tetramers could fit within a nanodomain of average size (~76 nm in 
diameter; Table 5.1). However, we regard the nanodomain occupancy estimate as a lower 
limit for the following reasons: 1) a portion of the population of labeling Fabs will bind but 
have no dye conjugated to them; 2) whether, at saturation binding conditions for the primary 
antibody, every DC-SIGN can be labeled due to steric hindrance between adjacent binding 
antibodies; and 3) whether one bivalent primary antibody can bind two proximate DC-SIGN 
molecules. Nevertheless, even if the average number of DC-SIGN molecules in nanodomains 
was underestimated by a factor of two to three, the nanodomain would not be fully occupied 
by close packed DC-SIGN proteins (Fig. 5.7). 
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5.4.7 DC-SIGN Does Not Significantly Co-Localize with CD206 on the Nanoscale. 
 Wide-field fluorescence microscopy indicates that in a significant fraction of cases, 
Dectin-1 or CD206 co-localize with DC-SIGN on the resolution level of the light microscope 
[9]. Whether this result holds on the nanoscale has important implications for membrane 
function. It is likely that whether CTLs are separated into different elemental nanodomains 
and/or co-mingled in the same nanodomain will regulate their downstream signaling (i.e., 
either by segregating downstream enzymes and substrates or by providing coincidence of two 
pathways both impinging on common downstream targets). Two-color Blink Microscopy 
using Atto655 and Alexa546 to label the two different secondary antibody Fabs was applied 
to test whether DC-SIGN and CD206 are co-localized on the nanoscale (Fig. 5.6, 
Supplemental Fig. 5.3). To optimize the blinking of both fluorophores for two-color 
measurements, some cells were imaged in an alternative solution that achieved oxygen 
removal enzymatically (2% glucose in PBS with 50 µg/ml glucose oxidase, 100-200 µg/ml 
catalase, 0.1 mM TCEP-HCl (Sigma)) and contained 1- 50 mM cysteamine (MEA, Sigma) as 
a reducing agent. Approximately the same % co-localization is calculated for both the two-
color Blink images (20 images analyzed) and for simulated images (100 images analyzed) of 
two overlapping randomly distributed sets of nanodomains (3.4 ± 1.9 and 1.9 ± 0.1 %, 
respectively, Supplemental Fig. 5.3). This super-resolution imaging determined that these 
two different CTLs are generally confined to separate nanodomains, and rarely co-exist 
within the same nanodomain. 
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5.5 DISCUSSION 
 
 How certain receptors are laterally organized on the membrane to enable binding to a 
large variety of potential ligands, and the interactions of these receptors with other membrane 
proteins and lipids that enable downstream signaling and internalization, remains a 
significant open question in biology. DC-SIGN, a CTL, forms clusters on the plasma 
membrane and these clusters subsequently bind to a diverse range of pathogens, ranging in 
size, surface composition, and infection route [4, 5]. The specific manner in which DC-SIGN 
clustering enables the receptor to bind to such pathogens is under active investigation [33-
37]. In this work, we have investigated the distribution of DC-SIGN and another CTL, 
CD206, on dendritic cells using a super-resolution imaging technique, Blink Microscopy, 
which has a positional precision (FWHM) for a single dye on glass of ~40 nm.  For 
reference, Blink was also used to image HA expressed on murine fibroblasts. 
 
 Blink Microscopy indicates that DC-SIGN and CD206 are organized into ~80 nm 
nanodomains on the surface of dendritic cells that cannot be resolved by widefield 
fluorescence microscopic methods. Thus, super-resolution [38, 39] and ultrastructural 
methods [5] are required to reveal this unexpected substructure. Interestingly, the viral 
influenza hemagglutinin protein, which forms dynamic clusters on the plasma membrane 
during viral budding, is also organized in ~80 nm nanodomains on the surface of a stable cell 
line that ectopically expresses HA. However, the overall lateral distribution of CTLs (DC-
SIGN and CD206) and HA nanodomains in the plane of the plasma membrane differs 
greatly. In the case of DC-SIGN and CD206, nanodomains are randomly distributed on the 
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cell surface, whereas, in the case of HA, the nanodomains are clustered on length scales up 
to, and sometimes beyond, 1 µm, consistent with earlier studies [28]. Moreover, HA can 
exchange between its microdomains and the surrounding membrane on a rapid time-scale, 
whereas DC-SIGN cannot [9]. In the case of HA, which must assemble into domains capable 
of enclosing a virions of ~100 nm in diameter, the propensity to cluster and to be expressed 
in a specific lipid environment may be selecting for a non-random distribution of clusters 
across the cell surface.  
 
 Furthermore, as Blink Microscopy is based upon the sequential localizations of single 
dyes used for immunofluorescent labeling, it is possible to estimate the occupancy of DC-
SIGN in nanodomains. This calculation is accomplished by dividing the number of Blink 
localizations per nanodomain by the average number of Blink localizations for a single Fab. 
This analysis estimates that a DC-SIGN nanodomain contains on average, and as a lower 
bound, 1-3 tetramers, suggesting both that DC-SIGN is not densely packed within 
nanodomains (Fig. 5.7) and that other proteins and lipids occupy such nanodomains. Thus, in 
the absence of ligand, DC-SIGN receptors are organized to have a 4- to 12- fold increased 
valency, at a minimum, compared to a single receptor. This multi-valency, in combination 
with the extreme lateral stability of the microdomains [8, 9], may allow the nanodomains to 
more effectively interact with weakly-binding antigen. Interestingly, it has been proposed 
that only a single HIV-1 Env (envelope glycoprotein) trimer is capable of initiating viral 
entry [40]. Furthermore, two-color Blink Microscopy determined that microdomains that 
appear by widefield microscopy to contain multiple CTLs are comprised of discrete 
nanodomains containing only one type of CTL that are positioned close to one another.  
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 Our results raise a number of important questions for the manner in which DC-SIGN 
and other CTLs carry out their biological function, and also provide new information that 
will be useful for understanding the relationship between composition, structure and 
dynamics for other clusters of plasma membrane receptors in cell biology. First, will the 
disposition of some membrane proteins (e.g., DC-SIGN and CD206) into elemental 
nanodomains prove to be a paradigm for certain classes of receptors? Second, what other 
components reside in the DC-SIGN and CD206 nanodomains and how are these 
nanodomains stabilized? For DC-SIGN, these questions are particularly intriguing because 
microdomain stability appears not to depend directly on the presence of the cytoplasmic 
domain but rather on the ectodomain of the protein [9, 41]. Third, from an immunological 
point of view, how does the distribution of DC-SIGN nanodomains adjust to accommodate 
large and small pathogens with different glycan patterns on their surfaces? Answers to these 
questions will substantially increase our understanding of membrane domain structures, their 
relation to function and, in the case of DC-SIGN and other CTLs, perhaps provide clues for 
the design of new therapeutic agents for human infectious diseases. 
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5.7 FIGURE LEGENDS 
 
Figure 5.1. Blink Microscopy on DC-SIGN plasma membrane nanodomains. (A) Image 
of DC-SIGN expression on a fixed dendritic cell stained with DC6 and anti-mouse 
ATTO655-Fab using diffraction-limited TIRF illumination. (B) Super-resolution Blink 
Microscopy image of DC-SIGN expression of the same region in (A). (C) Overlay of TIRF 
image (in red) and Blink image (in white). Scale bars, 500 nm; Scale bar inset, 100 nm. 
 
Figure 5.2. Determining DC-SIGN nanodomain size using Blink Microscopy. Super-
resolution Blink Microscopy image of DC-SIGN expression on a fixed dendritic cell stained 
with DC6 and anti-mouse ATTO655-Fab. The density of Blink localizations is denoted with 
black being least dense and white being most dense. Scale bar, 500 nm. A close-up view of 
the Blink localizations in a single DC-SIGN nanodomain, highlighted in the white box, 
appears to the right of the original image (Scale bar, 50 nm). A graph showing the 
distribution of the Blink localizations in the nanodomain in the x-dimension appears above 
the Blink image of the single nanodomain, and the Gaussian fit along the x-axis is shown 
with the black line. The data in the y-dimension are depicted in the graph in a vertical 
orientation to the right of the Blink image of the single nanodomain, and the Gaussian fit 
along the y-axis is shown with the red line. 
 
Figure 5.3. Size estimation of DC-SIGN, CD206, and HA plasma membrane 
nanodomains using Blink Microscopy. FWHM values obtained by Blink Microscopy of 
single ATTO655-Fab molecules (black bars), DC-SIGN nanodomains on dendritic cells 
stained with DC6 and anti-mouse ATTO655-Fab (blue bars), CD206 nanodomains on 
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dendritic cells stained with AF2534 and anti-goat ATTO655-Fab (green bars), and HA 
nanodomains on HAb2 cells stained with FC125 and anti-mouse ATTO655-Fab (red bars). 
As shown, DC-SIGN, CD206 and HA nanodomains all have similar size distributions. The 
average nanodomain size is much larger than the spatial accuracy of the method as 
determined by imaging single ATTO655-Fab molecules and is much smaller than the 
conventional wide field fluorescence microscopy resolution limit. 
 
Figure 5.4. DC-SIGN and CD206, but not HA, nanodomains are randomly distributed 
on the plasma membrane. (A,D,G) Binarized super-resolution Blink Microscopy images 
(cropped to exclude cell borders) of DC-SIGN expression on dendritic cells stained with 
DC6 and anti-mouse ATTO655-Fab (A), of CD206 expression on dendritic cells stained with 
AF2534 and anti-goat ATTO655-Fab (D), or of HA expression on HAb2 cells stained with 
FC125 and anti-mouse ATTO655-Fab (G); these images are representative of a collection of 
16, 13, and 12 analyzed for DC-SIGN, CD206, and HA, respectively. (B,E,H) Results of a 
modified Hopkin’s test for spatial randomness on centroids of DC-SIGN (B), CD206 (E), or 
HA (H) nanodomains (in blue) from the images in (A), (D), and (G), respectively. The 
distribution expected if the centroids were distributed randomly is depicted with the red lines. 
A non-random distribution or clustering would be indicated by a shift in the distribution to 
the right or left. (C,F,I) Results from a Ripley’s K test for spatial randomness on centroids of 
DC-SIGN (C), CD206 (F), or HA (I) nanodomains (black lines) from the images in (A), (D), 
and (G), respectively. The red lines indicate the 95% confidence interval for complete spatial 
randomness calculated from 1000 Monte Carlo simulations of random distributions of 
centroids. Scale bars, 500 nm.  
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Figure 5.5. Estimated occupancy of DC-SIGN, CD206, and HA in single nanodomains 
using Blink Microscopy. (A) Histogram of the number of Blink localizations for single 
ATTO655-Fab antibodies on glass (black bars), single DC-SIGN nanodomains on dendritic 
cells stained with DC6 and anti-mouse ATTO655-Fab (blue bars), CD206 nanodomains on 
dendritic cells stained with AF2534 and anti-goat ATTO655-Fab (green bars), and HA 
nanodomains on HAb2 cells stained with FC125 and anti-mouse ATTO655-Fab (red bars). 
(B) Histogram of the minimum number of DC-SIGN molecules per nanodomain on dendritic 
cells (red bars), of CD206 molecules per nanodomain on dendritic cells (green bars), and of 
HA molecules per nanodomain on HAb2 cells (red bars). Minimal occupancies for each 
nanodomain type were determined by dividing the number of blink localizations per 
nanodomain by the average number of blink localizations for a single Fab on glass.  
 
Figure 5.6. DC-SIGN and CD206 plasma membrane nanodomains are usually spatially 
distinct. Overlay image of DC-SIGN (green) and CD206 (red) expression on a dendritic cell 
stained with DCN46, anti-mouse Alexa546, AF2534 and anti-goat ATTO655-Fab using two-
color Blink Microscopy. Regions in yellow boxes are shown at higher magnification to the 
right and show examples of significant overlap (top), minor overlap (middle) and no overlap 
(bottom); the latter is the most prevalent situation by far. Scale bar, 500 nm; Scale bars 
insets, 100 nm.  
 
Figure 5.7. Model of occupancy of DC-SIGN in single nanodomains. A schematic 
depicting the distribution of DC-SIGN tetramers (in green) in a single DC-SIGN nanodomain 
(blue) on a dendritic cell. If the entire area of a ~76 nm in diameter nanodomain was 
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occupied by DC-SIGN tetramers (~8 nm in diameter [31, 32]), one would expect ~90 
tetramers to be in a single nanodomain. However, data using the super-resolution Blink 
Microscopy imaging method indicates that, as a lower limit, as few as 1-3 tetramers occupy a 
single DC-SIGN domain, leaving room for many other receptors and lipids to co-occupy the 
nanodomains. 
 
5.8 SUPPLEMENTAL FIGURE LEGENDS 
 
Supplemental Figure 5.1. Convolution of Blink Microscopy images of DC-SIGN plasma 
membrane nanodomains. (A) Image of DC-SIGN expression on a dendritic cell stained 
with DC6 and anti-mouse ATTO655-Fab using diffraction-limited TIRF illumination. (B) 
Super-resolution Blink Microscopy image of DC-SIGN expression of the same region in (A). 
(C) Overlay of convoluted Blink image (A, in red) and Blink image (B, in white). Scale bars, 
500 nm. 
 
Supplemental Figure 5.2. Single-step photobleaching of individual ATTO655-Fabs. 
Histogram of the number of single photobleaching steps from individual Atto655-Fabs on 
glass. Mean: 1.4, median: 1, stdev: 0.54, min: 1, max: 3, count= 46. 
 
Supplemental Figure 5.3. Assessement of overlap between two-color CD206 and DC-
SIGN Blink Microscopy images and two simulated random distributions of clusters. (A) 
Representative overlay image of DC-SIGN (green) and CD206 (red) expression on a 
dendritic cell stained with DCN46, anti-mouse Alexa546 IgG, AF2534 and anti-goat 
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ATTO655-Fab. The image was acquired by using two-color Blink Microscopy (one of 20 
analyzed). (B) A representative simulated Blink Microscopy image of two randomly arranged 
clusters (one of 100 analyzed). (C) A graph comparing the calculated % colocalization of 
DC-SIGN and CD206 from two color Blink images and from simulated images of two 
randomly distributed sets of clusters, in which any overlap is of a stochastic nature (20 and 
100 images analyzed, respectively). Error bars represent standard deviations. (D,E) A 
Ripley’s-K bivariate analysis is shown as L(t)-t (solid black line) for the representative 
analyzed image for DC-SIGN with CD206 (D), and the representative simulated Blink 
Microscopy image of two randomly arranged clusters (E). When L(t)-t is between the dashed 
lines (randomness confidence interval), the distribution is considered random; clustering is 
indicated when the L(t)-t is above the dashed lines. Scale bars, 1 µm. 
 
TABLE 5.1 
 
Characteristics of DC-SIGN, CD206, and HA nanodomains as measured by Blink Microscopy* 
 DC-SIGN Domains CD206 Domains HA Domains Single ATTO655-Fabs 
 
Mean 
(Median) 
 
Range 
n 
(m) 
Mean 
(Median) Range 
n 
(m) 
Mean 
(Median) Range 
n 
(m) 
Mean 
(Median) Range 
n 
(m) 
Overall 
FWHM 
(nm) 
 
 
76 ± 42 
 
(66) 
20-991 3706 
 
(17) 
70 ± 41 
 
(59) 
17-300 2819 
 
(13) 
74 ± 47 
 
(61) 
24-486 2910 
 
(12) 
39 ± 11 
 
(38) 
24-91 191 
 
(6) 
 
Area (nm2) 
 
 
5100 ± 
6100 
 
(3300) 
 
 
670- 
80814 
 
 
1853 
 
 
(17) 
4400 ± 
4700 
 
(2800) 
360- 
45247 
1409 
 
 
(13) 
5200 ± 
7800 
 
(2900) 
559- 
90554 
1455 
 
 
(12) 
1200 ± 
580 
 
(1200) 
553- 
3285 
97 
 
 
(6) 
 
Number of 
Blink 
Localizations 
 
163 ± 
230 
 
(82) 
 
 
8-2283 1960 
 
 
(17) 
78 ± 168 
 
 
(24) 
5-2357 1409 
 
 
(13) 
120 ± 
142 
 
(71) 
11-
1688 
1099 
 
 
(12) 
25 ± 18 
 
 
(22) 
5-111 97 
 
 
(6) 
 
*Uncertainties are standard deviations. Parameters m and n are the numbers of images and nanodomains analyzed, respectively. 
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CHAPTER 6 
Conclusions and Outlook 
 
 
6.1 Surprising Stability of DC-SIGN Microdomains 
 The clustering of DC-SIGN is required for efficient pathogen binding and 
internalization [1], however the molecular interactions that mediate the clustering of DC-
SIGN were not known. Work presented in Chapter 4 of this dissertation extends previous 
work by our lab, which had demonstrated that DC-SIGN domains failed to recover 
fluorescence following photobleaching [2]. Three complementary fluorescence-based 
methods of analysis (i.e., fluorescence recovery after photobleaching (FRAP), line-scan 
fluorescence correlation spectroscopy, and defined valency Qdot tracking), determined 
that DC-SIGN is extremely restricted in terms of its mobility within microdomains and 
therefore does not exchange with DC-SIGN in the surrounding membrane on a 
measurable time-scale during FRAP experiments [3]. Conventional notions would 
suggest that such stability of a membrane protein would be regulated by interactions 
between the cytoplasmic tail of DC-SIGN and the membrane-apposed cytoskeleton. 
However, mutants of DC-SIGN in which the cytoplasmic tail was almost completely 
deleted still formed very stable microdomains on the plasma membrane [3, 4]. Recent 
work, led by Dr. Ping Liu, utilized a mutational strategy to determine that the molecular 
basis of DC-SIGN domain formation and stability resides in the extracellular region of 
the protein, specifically the carbohydrate recognition domain [4]. Further, administration 
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of two different actin-disrupting drugs did not affect DC-SIGN microdomain formation 
[4], which also supports a model in which the extracellular region of DC-SIGN mediates 
microdomain stability. 
 
6.2 Unexpected Composition, Structure and Distribution 
 of DC-SIGN Domains 
 Previous work using widefield microscopy had indicated that DC-SIGN 
assembles into microdomains ranging from below the diffraction limit (~300 nm) to over 
1.5 µm in diameter [2]. Two-color widefield microscopy experiments, presented in 
Chapter 4, suggested that DC-SIGN domains could contain other C-type lectin molecules 
and could also allow lipids to transverse through the microdomains [3]. These 
experiments suggested that DC-SIGN domains were not densely packed with protein, but 
instead are likely to contain other proteins and lipids, not yet identified. Further 
investigations using the super-resolution method of Blink Microscopy, in Chapter 5, 
determined that DC-SIGN is predominantly expressed in randomly distributed 
nanodomains, which are <80 nm in diameter, and that these nanodomains are randomly 
distributed across the cell surface [5].  Therefore, nanodomains could be in close 
proximity to one another so that they appeared much larger when viewed by widefield 
microscopy [5]. Analysis using Blink Microscopy [5] and preliminary results using 
quantitative total internal reflection fluorescence (TIRF) microscopy [6] estimate that 
DC-SIGN nano-/microdomains, respectively, generally contain fewer than 12 molecules, 
or three tetramers, as a lower limit. Additionally, DC-SIGN nanodomains do not 
generally co-localize with CD206 nanodomains [5]. Thus, proteins that appeared co-
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localized using standard widefield microscopy methods are found to be spatially distinct 
when viewed using methods with higher resolution. 
 
6.3 Relating Domain Characteristics to DC-SIGN’s Biological Function 
 The manner in which the characteristics of DC-SIGN domains directly relate to 
the biological functions of DC-SIGN is an area of ongoing investigation. It is possible 
that the extreme stability of DC-SIGN microdomains helps to maintain a particular 
intradomain structure that enables more efficient pathogen recognition and/or 
internalization. For example, a particular arrangement of tetramers, number of molecules, 
and/or spatial arrangement of carbohydrate recognition domains may increase the 
relatively weak binding avidity of a single carbohydrate recognition domain for high 
mannose glycan residues. Also, stability on the membrane may allow for stable 
recruitment of other proteins and lipids important for initiating downstream signaling 
events following pathogen recognition. And further, lack of diffusion on the membrane 
may also provide stability during rapid transport from sites of pathogen binding to the 
perinuclear region, which is the predominant site of internalization [2]. 
 
 Much still remains unknown regarding the regulation of DC-SIGN microdomain 
stability. Recent data suggests that mutation of one of the seven residues involved in 
calcium binding in DC-SIGN’s carbohydrate recognition domain results in loss of 
microdomain formation and dynamic diffusion of DC-SIGN in the plasma membrane [4]. 
Therefore, it appears that active binding interactions between saccharides and the 
extracellular domain of DC-SIGN are responsible for DC-SIGN’s ability to form stable 
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domains on the plasma membrane. However, whether DC-SIGN is regulated by 
saccharides present in the extra cellular matrix, on glycosoylated transmembrane adaptor 
proteins linked to the membrane-apposed cytoskeleton, or present on a currently 
unidentified source is an area of ongoing investigation.  Further, whether or not release of 
such saccharide binding, either by direct competition with another saccharide and/or 
steric hindrance at the binding site, would also inhibit DC-SIGN’s ability to form 
domains, and therefore the ability of DC-SIGN to bind and internalize pathogens, 
remains a possibility. An important step in identifying the factors regulating DC-SIGN 
stability is identifying the proteins and lipids that interact with DC-SIGN. A proteomics-
based investigation on identifying proteins that are pulled-down with beads coated with 
DC-SIGN IgG is ongoing and will be key to answering many of these remaining 
questions.  These investigations are especially important considering the fact that DC-
SIGN exists in clusters much smaller than the diffraction limit, and that proteins that 
appear co-localized using widefield microscopy methods actually reside in distinct, 
though proximate locations. 
 
 All of the work presented in this dissertation was performed in the absence of 
pathogens. However, it is now known that DC-SIGN and CD206 assemble into large 
patches (> 2µm in diameter) at pathogen contact sites with yeast particles and that the 
interaction between the yeast particle and CD206 drives the formation of the “fungipod,” 
an actin-rich cell extension that stably attaches to the yeast [7]. Identifying the manner in 
which DC-SIGN nanodomains assemble into the large patches when incubated with yeast 
particles may provide important insight into the regulation of DC-SIGN diffusion and 
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pathogen recognition by DC-SIGN. Super-resolution imaging of dendritic cells that have 
been exposed to pathogens will provide important information regarding the structure of 
the DC-SIGN domains.  And further, super-resolution imaging of cells following the time 
course of pathogen recognition and internalization and/or with a variety of ligands will 
identify important steps in the regulation of DC-SIGN pathogen recognition. In all, C-
type lectin domains emerge as a new and unique model of how stable protein aggregation 
in the plasma membrane can lead to important biological function. 
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